Oncogenic STRAP regulates c-Jun stability and persistent migration by Reiner, Jennifer Elisabeth
  
ONCOGENIC STRAP REGULATES c-JUN STABILITY AND PERSISTENT 
MIGRATION 
By 
Jennifer Elisabeth Reiner 
 
 
Dissertation 
Submitted To the Faculty of the 
Graduate School of Vanderbilt University 
in partial fulfillment of the requirements 
for the degree of 
DOCTOR OF PHILOSOPHY 
in 
Cancer Biology 
August, 2011 
Nashville, TN  
 
 
APPROVED: 
Dr. Pran K. Datta 
Dr. Ann Richmond 
Dr. Pierre Massion 
Dr. Brian Wadzinski 
 
  
 ii 
 
ACKNOWLEDGEMENTS 
 
It would be impossible for me to adequately express my gratitude for all the 
assistance that I have received during my graduate studies at Vanderbilt.  The list of 
people who have offered advice and support during this process is quite long but I will do 
my best to mention those who have had the most significant impact on my education 
and completion of my doctorate.   
I would like to start by thanking the members of my thesis committee: Dr. Ann 
Richmond, Dr. Brian Wadzinski, Dr. Pierre Massion, and Dr. Pran Datta.  Their 
suggestions and willingness to proofread several drafts of my manuscripts were 
immensely helpful to me.  I would particularly like to thank Dr. Ann Richmond for her 
unwavering support and everything she has done for me.  Dr. Richmond's willingness to 
engage and offer suggestions on my projects was instrumental to my work.  I would like 
to sincerely thank Dr. Hal Moses for extending his lab and resources to me during 
difficult times.  I also want to extend my gratitude to Dr. Lynn Matrisian and Dr. Roger 
Chalkley for their assistance.  I would certainly not have reached this point without all of 
your strong support.   
I would like to thank Dr. Jiquing Sai in the Richmond lab for his technical advice 
and allowing me to use his chemotaxis devices.  I am grateful to Dr. Ye Fei and Greg 
Ayers for their assistance with the statistical analysis of my data.   I would like to thank 
Dr. Steve Haan for generously providing the c-myc custom antibody and Dr. Bill Tansey 
and Dr. Steve Hanks for their willingness to share their scientific expertise on 
ubiquitylation and FAK signaling, respectively.   
I would also like to thank Chirie Sumanasekera for her friendship, aliquots of 
gumbo, and helpful suggestions regarding my experiments and manuscripts.  I am also 
 iii 
 
grateful to Wanguang Zhang in the Datta lab for his good humor and friendship.  Of 
course, a big thank you goes out to all the members of the Moses Lab for their 
generosity and hospitality.   
Apart from the Vanderbilt community, there have been a few key people who 
have supported me and helped me maintain some semblance of sanity through the 
years.  I am grateful to Kathy Perkins for her friendship and support.  Last but not least, I 
would like to thank my parents, Ivan and Jun Reiner.  Since I was young, my parents 
have always supported me in my endeavors and have made significant sacrifices for my 
benefit.  They have been a constant source of support and advice.   
The path to completing my doctorate at Vanderbilt has been a long and 
sometimes rocky one.  Having had the opportunity to interact with many accomplished 
scientists, I have come to admire those who are of good character and treat others with 
respect.  So, I have learned that to be a success in science, it is both important to be a 
good scientist and a good person.  I would like to express my sincere gratitude to all the 
people mentioned above who have offered their love, friendship, support, and advice. 
 
 
 
  
 iv 
 
 
Page 
ACKNOWLEDGEMENTS ................................................................................................ ii 
TABLE OF CONTENTS ................................................................................................. iv 
LIST OF FIGURES ........................................................................................................ vii 
LIST OF TABLES ........................................................................................................... ix 
LIST OF ABBREVIATIONS ............................................................................................. x 
Chapter  
I.   INTRODUCTION ........................................................................................................ 1 
STRAP ................................................................................................................. 2 
Characterization of STRAP....................................................................... 2 
SMAD-dependent and -independent TGF-β signaling .............................. 6 
STRAP mediated inhibition of TGF-β signaling ......................................... 9 
STRAP association with NM23-H1 affects the TGF-β and p53 signaling  
pathways ................................................................................................ 10 
STRAP promotes cell survival by regulating ASK1 and PDK1  
signaling ................................................................................................. 11 
STRAP regulates cell growth signaling pathways ................................... 12 
The role of STRAP in transcription, mRNA splicing, and cap-independent  
translation ............................................................................................... 14 
STRAP expression is associated with mesenchymal  
morphology in MEFs .............................................................................. 16  
Clinical significance and targeted inhibition of STRAP ............................ 16 
The c-Jun proto-oncogene ................................................................................. 18 
The ubiquitin proteasome and c-Jun stability .......................................... 20 
Directed Migration .............................................................................................. 24 
Regulators of gradient sensing and cell polarity...................................... 24 
Cell adhesion and motility ....................................................................... 28 
Focal adhesion kinase signaling pathways ............................................. 32 
Summary and Aims ............................................................................................ 35 
 
II.   STRAP STABILIZES C-JUN AND PROMOTES CELLULAR PROLIFERATION ...... 37 
 
Introduction ........................................................................................................ 37 
Materials and methods ....................................................................................... 39 
Cell lines and plasmids ........................................................................... 39 
Reagents and antibodies ........................................................................ 39 
Generation of stable cell lines ................................................................. 39 
Western blot analysis ............................................................................. 40 
Cell growth assays ................................................................................. 41 
 v 
 
Reverse transcription PCR ..................................................................... 41 
Cycloheximide assay .............................................................................. 42 
Ubiquitylation assay ............................................................................... 42 
Results ............................................................................................................... 43 
STRAP regulates c-Jun protein expression and activation ..................... 43 
STRAP does not regulate c-Jun mRNA or JNK activation ...................... 46 
STRAP inhibits ubiquitin-mediated proteolysis of c-Jun  ......................... 48 
STRAP prolongs the half-life of c-Jun ..................................................... 50 
Stable reintroduction of STRAP rescues the c-Jun instability  
defect in STRAP knockout fibroblasts ..................................................... 50 
STRAP promotes proliferation of MEFs .................................................. 52 
Discussion ......................................................................................................... 52 
 
III.  STRAP PROMOTES PERSISTENT MIGRATION AND TAIL  
      RETRACTION DURING CHEMOTAXIS .................................................................. 58 
 
Introduction ........................................................................................................ 58 
Materials and methods ....................................................................................... 62 
Cell culture and plasmids ....................................................................... 62 
Reagents and antibodies ........................................................................ 62 
Generation of stable cell lines ................................................................. 62 
Immunofluorescence .............................................................................. 63 
Transwell migration assay ...................................................................... 63 
Wound closure assay ............................................................................. 64 
Live cell imaging ..................................................................................... 65 
Uropod formation and retraction ............................................................. 65 
AKT localization ...................................................................................... 66 
Adhesion assay ...................................................................................... 66 
Cell Spreading assay.............................................................................. 67 
Focal adhesion disassembly assay ........................................................ 67 
Western blot analysis ............................................................................. 68 
Results ............................................................................................................... 69 
STRAP is a positive regulator of cell migration ....................................... 69 
Loss of STRAP increases cell adhesion and spreading .......................... 71 
STRAP regulates persistent chemotactic migration ................................ 73 
Loss of STRAP is associated with decreased tail retraction and  
altered phospho-FAK Y397 distribution .................................................. 75 
Ectopic expression of STRAP rescues the defect in directed  
migration and attenuates tail formation ................................................... 79 
STRAP regulates FAK subcellular localization........................................ 82 
Discussion ......................................................................................................... 84 
 
 
 
 
IV.  CONCLUSIONS AND FUTURE DIRECTIONS ....................................................... 88 
Significance of STRAP-mediated c-Jun stabilization and  
future directions ................................................................................................. 88 
 
 vi 
 
Biological implications for STRAP-induced persistent migration 
and future directions .......................................................................................... 90 
Concluding remarks ........................................................................................... 94 
 
REFERENCES .............................................................................................................. 97 
 vii 
 
LIST OF FIGURES 
 
                      Page 
Figure 1:   Developmental defects associated with STRAP mutation ............................... 3 
Figure 2:   STRAP protein domains and structural motifs ................................................ 4 
Figure 3:   SMAD-dependent and SMAD-independent TGF-β signaling pathways  
                 (simplified) ...................................................................................................... 8 
 
Figure 4:   STRAP promotes survival by regulating PDK1 and ASK1 signaling .............. 13 
 
Figure 5:   Functional domains in c-Jun and v-Jun ......................................................... 19 
 
Figure 6:   The Ubiquitin Proteasome Pathway .............................................................. 22 
 
Figure 7:  Mechanisms regulating gradient sensing and cell polarization ....................... 27 
 
Figure 8:  Focal adhesion architecture and interactome (simplified) .............................. 31 
 
Figure 9:  Comparison of FAK and PYK2 functional domains ........................................ 34 
 
Figure 10:   STRAP expression correlates with increased activation and  
                 expression of c-Jun ....................................................................................... 44 
 
Figure 11:   Effects of STRAP on the expression of various transcription factors ........... 45 
 
Figure 12:   STRAP does not regulate c-Jun mRNA levels or JNK activation................. 47 
 
Figure 13:  STRAP stabilizes c-Jun by inhibiting ubiqutin-mediated proteolysis of 
                  c-Jun ............................................................................................................ 49 
 
Figure 14:  STRAP prolongs the half-life of c-Jun and increases c-Jun expression in 
                  STRAP knockout fibroblasts ........................................................................ 51 
 
Figure 15:  STRAP expression promotes cellular proliferation ....................................... 53 
 
Figure 16:  STRAP regulation of cell growth pathways promotes cell autonomous and 
                  paracrine-stimulated growth ......................................................................... 57 
 
Figure 17:  STRAP suppresses E-cadherin expression in MEFs ................................... 59 
 
Figure 18:  STRAP expression promotes cell migration ................................................. 70 
 
Figure 19:  Loss of STRAP promotes cell adhesion and spreading ............................... 72  
 
Figure 20:  STRAP is required for persistent chemotaxis ............................................... 74 
 viii 
 
 
Figure 21:  Loss of STRAP does not inhibit AKT membrane recruitment ....................... 76 
 
Figure 22:  STRAP is required for efficient tail retraction during chemotaxis .................. 77 
 
Figure 23:  Loss of STRAP alters the distribution of phospho-FAK Y397 ....................... 78 
 
Figure 24:  Reintroduction of STRAP into the STRAP null MEFs increases  
                  cell migration ............................................................................................... 79 
 
Figure 25:  Ectopic STRAP in STRAP null fibroblasts reduces tail growth ..................... 81 
 
Figure 26:  STRAP regulates phospho-FAK localization ................................................ 83 
 
Figure 27:  Biological effects of STRAP on the hallmarks of cancer ............................... 96 
 
 ix 
 
LIST OF TABLES 
 
Page 
Table 1.  Regulators of c-Jun stability ............................................................................ 23 
 
Table 2.  Integrin pairings and cognate ligands .............................................................. 29 
 
Table 3:  Epithelial and mesenchymal markers expressed by wild type  
and STRAP null MEFs ................................................................................................... 60 
 
Table 4:  Mouse models for assessing the effects of STRAP on AP-1 
induced cell autonomous and paracrine growth ............................................................. 91 
 
 
 x 
 
LIST OF ABBREVIATIONS 
 
 
5-FU 5-Fluorouracil  
AD Activation domain 
AP-1 Activating protein-1 
ARP 2/3 Actin related protein 2/3 
ASK1    Apoptosis Signal-Regulating Kinase 1 
ATF    Activating transcription factor 
B-MYB    B-myeloblastosis  
BPH    Benign prostatic hyperplasia 
cAMP    cyclic AMP 
CAF    Cancer-associated fibroblasts 
CaN    Calcineurin 
CSK    COOH-terminal SRC kinase 
CDK    Cyclin-dependent kinase 
COP1    Constitutively photomorphogenic protein 1 
DBD    DNA-binding domain 
DET1    De-etiolated-1 
DOCK    Dedicator or cytokinesis 
ECM    Extracellular matrix 
ELMO    Engulfment of cell motility 
EWS    Ewing Sarcoma Protein 
EMT    Epithelial to Mesenchymal Transition 
ERK    Extracellular Signal-Regulated Kinase 
FAK    Focal adhesion kinase 
FRET    Fluorescence resonance energy transfer 
FBW7    F-box and WD repeat domain-containing 7 
GSK3-β   Glycogen synthase kinase 3-beta 
GM-CSF   Granulocyte Macrophage-colony stimulating factor 
GPCR    G-protein coupled receptor 
HB-EGF   Heparin binding-Epithelial-like growth factor 
H2O2    Hydrogen peroxide 
HNF4    Hepatocyte nuclear factor 4 
I-SMAD   Inhibitory SMAD 
IRES    Internal ribosome entry site 
JDP    Jun dimerization protein 
JNK    c-Jun N-terminal Kinase  
kDa    kiloDaltons 
KGF    Keratinocyte growth factor  
MAPK    Mitogen activated protein kinase  
MDM2    B-myeloblastosis 
MEFs    Mouse Embryonic Fibroblasts 
MEK    Mitogen-activated protein kinase/extracellular signal-  
    regulated kinase kinase 
MET    Mesenchymal to epithelial transition 
MKK1    MAP kinase kinase 1    
MMP28   Matrix metalloproteinase 28 
NDP    Nucleotide diphosphate 
NLS    Nuclear localization signal 
 xi 
 
PAK1    p-21 activated kinase 1 
PARP    Poly(ADP)-ribose polymerase 
PCR    Polymerase chain reaction 
PDK1    Phosphoinositide-dependent Kinase 1 
PI3K    Phosphoinoside-3-kinase 
PIP2    Phosphatidylinositol 4,5-bisphosphate  
PIP3    Phosphatidylinositol 4,5-triphosphate 
PH    pleckstrin homology  
PKC    Protein kinase C 
PYK2    Protein tyrosine kinase 2 
R-SMAD   Receptor-associated SMAD 
RACO-1   RING domain AP-1 co-activator-1 
RT-PCR   Reverse transcription-PCR 
S6K    S6 ribosomal kinase 
SCID    Severe combined immunodeficiency 
SMN    Survival of motor neurons 
snRNP    small nuclear ribonucleoprotein 
STAT3    Signal transducer and activator of transcription 3 
STRAP   Serine Threonine Kinase-Receptor Associated Protein 
TBRI    TGF-β receptor I 
TBRII    TGF-β receptor II 
TGF-β    Transforming Growth Factor-Beta 
TRE    TPA-response element 
Trx    Thioredoxin 
WASP    Wiskott-Aldrich syndrome protein 
UNRIP    Unr-interacting protein 
 
 
 
 
 
  
Chapter I 
 
INTRODUCTION 
 
 Since its initial discovery as an inhibitor of canonical Transforming Growth 
Factor-β (TGF-β) signaling, the serine-threonine kinase-receptor associated protein 
(STRAP) has been reported to regulate a wide array of biological processes and 
intracellular signaling pathways.  At the organismal level, STRAP appears to have an 
essential role in development, as homozygous deletion of STRAP has been reported to 
cause morphological defects and embryonic lethality (Chen et al., 2006).  At the cellular 
level, STRAP has been shown to affect cell survival and apoptosis through distinctly 
different mechanisms (Seong et al., 2005; Jung et al., 2010).  While these studies 
suggest that STRAP is important for development and cellular homeostasis, 
deregulation of STRAP may drive pathological conditions.  When considering the many 
roles of STRAP, it appears that most of the signaling pathways and biological functions 
of STRAP favor tumor promotion rather than tumor suppression (Reiner and Datta, 
2011).  In fact, it has previously been shown that STRAP confers oncogenic properties 
to cells in anchorage-independent growth assays and xenograft models of cancer 
(Halder et al., 2006).   At the present time, a comprehensive understanding of the 
mechanisms by which STRAP influences normal and pathological cellular functions is 
unknown. Further investigation into the biological functions of STRAP will be critical not 
only to understanding the complexities of STRAP-mediated signal transduction but may 
also play an important role in the development of targeted anti-cancer therapeutics.   
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STRAP 
 
Characterization of STRAP 
 STRAP is an evolutionarily conserved protein with an apparent molecular weight 
of 38 kilodaltons (kDa).  STRAP, which was initially cloned from a mouse cDNA library, 
was reported to be broadly expressed in mouse (Datta et al., 1998) and human tissue 
(Matsuda et al., 2000).  Computational analyses indicate that STRAP orthologues may 
be present in a wide range of species including chimpanzees, Drosophila, and 
Arabidopsis but functional redundancies have not been experimentally determined.  The 
genomic loci for human STRAP has been mapped to chromosome 12p11-12 (Matsuda 
et al., 2000) whereas the murine orthologue is located on chromosome 6.  
 Although broad tissue expression is not sufficient to classify STRAP as a 
“housekeeping” gene, loss of STRAP has been reported to affect normal development.  
Homozygous deletion of murine STRAP by gene-trap mutagenesis is embryonic lethal 
between days E10.5 and E12.5 (Chen et al., 2004).  Gross morphological examination of 
the STRAP knockout embryos revealed defects in angiogenesis, cardiogenesis, 
somitogenesis, and neural tube closure (Chen et al., 2004) (Figure 1).  Additionally, 
overexpression of the drosophila STRAP homolog, pterodactyl, has been reported to 
cause defects in wing development (Khokhar et al., 2008).   
 At the structural level, STRAP is comprised of seven WD40 domain repeats that 
fold into a β-propeller structure (Figure 2).  The WD40 repeat, also known as the 
transducin repeat, is comprised of approximately 40 amino acids with a conserved core 
sequence that terminates with a tryptophan-aspartic acid dipeptide.  WD40 repeat 
proteins seem to support the formation of stable and transient protein complexes by  
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Figure 1.  Developmental defects associated with STRAP mutation.  A.  E10.5 
STRAP knockout mice exhibit defects in yolk sac vascularization (top), neural tube 
closure, embryonic turning, cardiogenesis, and somitogenesis (bottom).  B. 
Homozygous insertion of a transposable element 3 bp upstream of STRAP (pter2-4) 
causes mild wing vein defects.  Excision derivatives (exc2-exc4) of the original pter2-4 
insertion exhibited more severe tubulogenesis defects.   
Reprinted from Nat Genet (2004) 36, 304-12 with permission from Nature Publishing Group 
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Figure 2. STRAP protein domains and structural motifs  A. The human STRAP 
gene encodes a 350 amino acid protein that contains 7 putative WD40 repeats.  B.  
Four dimensional representation of a 7-bladed WD40 protein.  The ribbon diagram 
(left) and globular structure (right) are viewed from a top-down perspective (structure 
shown is the WD40 domain of Tup1).   
Reprinted from Embo J (2000) 19,3016-27 with permission from Nature Publishing Group 
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functioning as a molecular scaffold (Stirnimann et al., 2010).  Apart from the WD40 
repeat, STRAP does not contain any discernable structural or functional domains.  
Deletion of the C-terminal 56 amino acids has been reported to decrease TGF-β 
receptor (TBR)-dependent (TBR)-dependent phosphorylation of STRAP, but no loss of 
function has been associated with this truncated mutant (Datta and Moses, 2000).   
 Previous studies have shown that STRAP is subject to post-translational 
modification in vivo.  It has been reported that the TGF-β receptors indirectly promote 
phosphorylation of STRAP within its C-terminus (Datta and Moses, 2000).  However, 
STRAP C-terminal phosphorylation is dispensable to repression of Smad transcriptional 
activity as a STRAP C-terminal deletion mutant was still able to inhibit transactivation of 
a TGF-β reporter (Datta and Moses, 2000).  Furthermore, phosphorylation of STRAP at 
T175 and S179 by ASK1 has been shown to promote complex formation with ASK1 
(Jung et al., 2010).  STRAP has also been reported to be a target of the small ubiquitin-
related modifier 4 (SUMO4) in serum starved 293 cells (Guo et al., 2005), but the 
functional consequences of sumoylation have not been investigated.   
 Functionally, STRAP has been reported to affect multiple protein signal 
transduction pathways, protein stability, and gene expression.  STRAP expression is 
required for normal developmental processes (Chen et al., 2004) and deregulation of 
STRAP has been implicated in tumorigenesis (Matsuda et al., 2000; Halder et al., 2006, 
Reiner and Datta, 2011).  Although STRAP does not contain a nuclear localization signal 
(NLS), STRAP has been detected in the cytoplasm and nucleus by immunofluorescence 
(Halder et al., 2006).  Taken together, these studies suggest that STRAP’s biological 
functions and subcellular localization are dependent on its association with other cellular 
proteins.   
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SMAD-dependent and SMAD-independent TGF-β signaling 
 The transforming growth factor beta (TGF-β) family of proteins regulates a broad 
array of biological functions such as growth, differentiation, EMT, invasion, and 
apoptosis.  The pleiotropic effects of TGF-β are achieved through activation of SMAD-
dependent and SMAD-independent signaling pathways (Engel et al., 1998; Derynck and 
Zhang, 2003).  Signaling through both pathways is initiated by an oligomeric complex  
comprised of the TGF-beta receptor (TBR) I and II homodimers (Figure 3).  TGF-β ligand 
binding to a heteromeric complex comprised of TGF-β receptor I (TBRI) and receptor II 
(TBRII) dimers induces phosphorylation of the TBRI cytoplasmic domain.  The activated 
TBRI/TBRII complex can then initiate SMAD-dependent signaling by phosphorylating the 
receptor associated SMADs (R-SMADS), SMAD-2 and SMAD-3 (Zhang et al., 1996; 
Nakao et al., 1997).  The activated SMAD-2/3 complex then binds to SMAD-4 (Zhang et 
al., 1996; Nakao et al., 1997) and translocates to the nucleus where it associates with 
other transcriptional regulators to activate or suppress transcription from TGF-β target 
genes such as p21Cip1, p15INK4a, and PAI-1 (Engel et al., 1998).  Although the specific 
gene expression profile induced by TGF-β/SMAD signaling varies according to cell type, 
the SMAD pathway is recognized as a tumor-suppressor pathway as SMAD activation is 
correlated with inhibition of cell cycle progression and induction of apoptosis.   
 In addition to activation of SMAD signaling, the TGF-β receptors can initiate Ras, 
p38 MAPK, JNK, RhoA, and PI3K signaling pathways.  However, activation of the 
SMAD-independent pathways have been associated with early stage tumor progression, 
particularly in cells that harbour inactivating mutations in the TGF-β receptors, R-
SMADs, and SMAD-4 (Elliott and Blobe, 2005).  Although the mechanism by which the 
TGF-β receptors activate SMAD-independent signaling have not been well 
characterized, activation of these pathways has been associated with proliferation,  
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Figure 3.  SMAD-dependent and SMAD-independent TGF-β signaling pathways 
(simplified).  Smad-dependent and Smad-independent TGF-β signaling is initiated 
through a ligand-bound oligomeric complex of TBRI and TBRII receptors.  
Phosphorylation of the SMAD-2/-3 complex by the activated TGF-β receptors promotes 
SMAD-4 binding and nuclear translocation.  The SMAD-2/-3/-4 complex then binds to 
SMAD-binding elements within the promoter regions of TGF-β target genes and 
functions in concert with other transcription factors to activate or inhibit gene expression.  
In addition to SMAD phosphorylation, the activated TGF-β receptors can activate RhoA 
as well as the JNK, p38 MAPK, and RAS MAP Kinase signaling pathways.  Generally, 
activation of the SMAD pathway is associated with growth inhibition and tumor 
supression whereas SMAD-independent signaling is correlated with increased 
tumorigenicity. 
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Figure 3.  SMAD-dependent and SMAD-independent TGF-β signaling pathways 
(simplified).  
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epithelial to mesenchymal transition (EMT), cellular migration, and survival (Yan et al., 
2002; Xie et al., 2004; Tavares et al., 2006; Wang et al., 2008; Kattla et al, 2008).  
Cooperation between the non-SMAD pathways has also been reported to induce 
malignant transformation in some cell lines (Erdogan et al, 2008; Fleming et al., 2009).   
 
STRAP-mediated inhibition of TGF-β-signaling 
 STRAP was initially identified in a yeast two-hybrid screen for proteins that 
 interact with TBRI (Datta et al, 1998).  Overexpression of STRAP was shown to 
decrease TGF-β mediated transcription in reporter assays using constructs containing 
SMAD-binding elements in the promoter region.  It was subsequently shown that STRAP 
forms a ternary complex with TBRI and SMAD-7, suggesting that the STRAP/SMAD-7 
complex blocks receptor mediated phosphorylation of the R-SMADs (Datta and Moses, 
2000).    
 Given that TGF-β SMAD signaling induces cell cycle arrest in normal cells, 
STRAP over-expression would be expected to confer resistance to the anti-proliferative 
effects of TGF-β.  Indeed, wild type mouse embryonic fibroblasts (MEFs) exhibit a 
greater capacity for proliferation in the presence of TGF-β compared to STRAP null 
fibroblasts (Halder et al., 2006).  Overexpression of STRAP in the lung adenocarcinoma 
cell line, A549, also results in a modest decrease in TGF-β induced growth inhibition 
relative to controls (Halder et al, 2006).  At the present time, STRAP involvement in 
TGF-β SMAD-independent signaling remains unclear.  It has been shown that 
overexpression of SMAD-7 in FET cells promotes activation of c-Jun in response to 
TGF-beta (Halder et al., 2005).  Likewise, loss of STRAP appears to inhibit c-Jun 
phosphorylation  and expression following TGF-β treatment (unpublished data).  These 
findings may suggest that STRAP cooperates with SMAD-7 to promote c-Jun activation.  
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Interestingly, TGF-beta mediated activation of p38 MAPK is inhibited by STRAP 
(unpublished data), suggesting that STRAP employs different mechanisms for regulating 
TGF-β SMAD-independent signaling.   
 
 
 
STRAP association with NM23-H1 affects the TGF-β and p53 signaling pathways 
 
The NM23-H1 tumor suppressor belongs to the DNA-binding nucleotide di-
phosphate (NDP) kinase family of proteins.  NM23-H1 is regarded as a favorable 
prognostic indicator of poorly metastatic tumors due to its reduced expression in 
aggressive late stage tumors (Rosengard et al., 1989; Leone et al., 1991; Hennessy et 
al., 1991).  In addition to its role as a metastasis inhibitor, NM23-H1 has also been 
reported to affect proliferation and differentiation of some cell lines (Lombardi et al, 2001; 
Yang et al., 2009).  Currently, the mechanisms whereby NM23-H1 affects these 
biological pathways are unknown but efforts to identify NM23-H1 binding partners may 
explain the diverse functions of this protein.   
 With respect to the TGF-beta signaling, previous studies have shown that 
NM23H-1 can antagonize TGF-beta induced anchorage independent growth (Leone et 
al., 1991; Leone et al., 1993).  However, data describing the effects of NM23-H1 
expression on TGF-beta mediated growth suppression are contradictory. Early studies 
suggest that NM23-H1 potentiates SMAD-dependent signaling in HT29 colon cancer 
cells as antisense NM23 blocks TGF-beta induced growth arrest (Hsu et al., 1994).  
Contrary to these findings, a recent study reports that NM23-H1 association with STRAP 
reduces transactivation of SMAD-dependent reporter genes and attenuates TGF-beta 
mediated apoptosis and growth arrest (Seong et al., 2007).  Subsequently, the NM23-
H1/STRAP complex was shown to directly bind and stabilize p53 by dissociating murine 
double minute 2 (MDM2) (Jung et al., 2007).  Although transactivation of some TGF-beta 
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responsive genes is dependent on p53 (Cordenonsi et al., 2003), the dual functions of 
STRAP/NM23-H1 appear to have conflicting effects on the canonical TGF-beta pathway.  
Like TGF-beta signaling, STRAP/NM23-H1 complex formation may yield different 
biological outcomes depending on the experimental context. Further investigation will be 
required to resolve these discrepancies.   
 
STRAP promotes cell survival by regulating ASK1 and PDK1 signaling 
 
 The apoptosis signal-regulating kinase 1 (ASK1) is a MAPKK protein that 
functions as an upstream activator of the stress kinases, p38 and JNK.  Under normal 
physiological conditions, ASK1 is maintained in an inactive state through its association 
with thioredoxin (Trx) or the adaptor protein, 14-3-3.  However, exposure to various 
chemicals and oxidative stress leads to its phosphorylation, dissociation from Trx and 
14-3-3, and apoptosis.  It has been reported that STRAP associates with ASK1 and 
stabilizes the interaction between ASK1 and Trx or 14-3-3 (Jung et al., 2010).  This 
interaction was shown to decrease hydrogen peroxide (H202)-dependent ASK1 activation  
and apoptosis in HEK293 cells although H202 treatment decreased physical association 
between STRAP and ASK1 (Jung et al., 2010).   In addition to STRAP, PDK1 has 
recently been shown to negatively regulate ASK1-induced apoptosis (Seong et al., 
2010).  PDK1 is a serine-threonine kinase that phosphorylates a wide array of signal 
transduction proteins including protein kinase C (PKC), S6 ribosomal kinase (S6K), p21-
activated kinase 1 (PAK1), and AKT.   Activation of PDK1 signaling has been implicated 
in cellular proliferation, survival, migration, and invasion of tumor cells as well as breast 
cancer resistance to tamoxifen (Choi et al., 2008; Liu et al., 2009; Peifer et al., 2009; 
Westmoreland et al., 2009).  Interestingly, STRAP has been reported to associate with 
PDK1 and promote phosphorylation of the PDK1 substrates S6K, AKT, and BAD (Seong 
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et. al, 2005).  Reciprocally, PDK1 binding to STRAP augmented STRAP mediated 
inhibition of TGF-β signaling but exogenous TGF-β attenuates PDK1/STRAP complex 
formation (Seong et al.,  2005).  PDK1 was subsequently reported to inhibit TGF-β 
signaling through direct association with SMADs-2, -3, -4, and -7 in the absence of TGF-
β (Seong et al., 2007).  Furthermore, STRAP overexpression was shown to promote 
PDK1 complex formation with the SMAD proteins (Seong et al., 2007).  These findings 
may suggest that negative regulation of TGF-β/SMAD signaling is achieved through 
STRAP's ability to function as a scaffold and recruit proteins into a macromolecular 
complex at the TGF-β receptors.   
 Taken together, these findings suggest that STRAP promotes viability through 
induction of the pro-survival PDK1 pathway and inhibition of pro-apoptotic ASK1 
signaling (Figure 4).  Although STRAP has been shown to interact with ASK1 and PDK1 
separately, it has not been reported whether these three proteins can form a ternary 
complex.  Further work will be required to fully elucidate the complex mechanisms by 
which these proteins coordinately regulate survival and apoptosis.  
 
STRAP regulates cell growth signaling pathways 
  Overexpression of STRAP has been reported to induce extracellular signal-
regulated kinase (ERK) activation in various cell lines (Matsuda et al., 2000; Halder et 
al., 2006).  Increased activation of ERK in Mv1Lu cells was coincident with increased 
pRb phosphorylation and decreased p21CIP1 expression (Halder et al., 2006).  
Importantly, STRAP regulation of these signaling proteins was independent of 
exogenous TGF-β treatment.  Although ERK activation was not shown to directly affect 
pRb phosphorylation, these findings may suggest that STRAP can affect cellular 
proliferation signaling pathways in a TGF-β-independent manner.   
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Figure 4.  STRAP promotes survival by regulating PDK1 and ASK1 
signaling.  PDK1 is maintained in an inactive conformation through association with 14-3-
3 or ASK1.  Insulin treatment promotes PDK1 dissociation from its negative regulators and 
association with STRAP.  The STRAP-PDK1 complex promotes cell survival through 
phosphorylation of PDK1 substrates and inhibition of SMAD activation.  ASK induces 
apoptosis in response to oxidative stress by phosphorylating the stress-induced kinases, 
p38 MAPK, and JNK.  ASK1 binding to PDK1, Trx, and 14-3-3 inhibits phosphorylation of 
ASK-1 substrates, thereby promoting cell survival.  STRAP inhibits ASK1-mediated 
apoptosis by stabilizing complex formation between ASK1 and Trx or 14-3-3.   
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.  The role of STRAP in transcription, mRNA splicing, and  
cap-independent translation 
 Apart from its role in the regulation of protein signaling pathways, several studies 
have reported a role for STRAP in the regulation of gene expression.  STRAP has been 
shown to associate with the Ewing Sarcoma protein, EWS, and attenuate EWS/p300 
dependent transcription of hepatocyte nuclear factor 4 (HNF4) reporter constructs 
(Anumanthan et al., 2006).  HNF4 is a nuclear receptor that regulates tissue-specific 
differentiation and proliferation.  Stable expression of HNF4 can restore a differentiated 
epithelial phenotype to hepatoma cells through induction of cytokeratins and E-cadherin 
(Spath et al., 1998).  Furthermore, HNF4-alpha expression can decrease proliferation 
and alter cellular morphology of 293T cells (Lucas et al., 2005).  These findings may 
suggest that STRAP can confer oncogenic properties to cells that require HNF activity 
for the maintenance of cellular differentiation and cell cycle progression.  A recent study 
reported that STRAP functions as a transcriptional cofactor for Sp1-mediated activation 
of the matrix metalloproteinase 28 (MMP28) (Swingler et al., 2010).  This finding is 
particularly interesting because this study provides the first functional account of STRAP 
activity within the nuclear compartment and may point to a role for STRAP in tumor 
metastasis.  In addition to EWS and Sp1, it has recently been shown that STRAP binds 
to the B-myeloblastosis (B-MYB) transcription factor (Seong et al., 2010).  B-MYB has 
been implicated in cell cycle progression, inhibition of apoptosis, and tumorigenesis 
(Sala 2005).  While the scope of this study was limited to the effects of B-MYB on 
STRAP-mediated inhibition of SMAD activation (Seong et al. 2010), STRAP associations 
generally exhibit reciprocity so it is plausible that STRAP can affect transactivation of B-
MYB target genes.   
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 STRAP may also regulate gene expression by affecting pre-mRNA splicing and 
cap-independent translation.  Pre-mRNA splicing is catalyzed by small nuclear 
ribonucleoproteins (snRNPs), which are assembled into a spliceosome by  
a multi-protein complex called the survival of motor neuron (SMN) complex (Pellizzoni et 
al., 1998).  It has been shown that STRAP is a component of the SMN complex and that 
immunodepletion of STRAP markedly reduces the assembly of snRNPs (Carissimi et al., 
2005).  Furthermore, nuclear accumulation of the SMN complex was observed following 
STRAP knockdown, suggesting that incorporation of STRAP is necessary for cytosolic 
localization (Grimmler et al., 2005).  Although there is no direct link between proper SMN 
complex function and cancer, patients carrying homozygous mutations in the SMN1 
gene develop the progressive neuromuscular degenerative disease, spinal muscular 
atrophy (Rodrigues et al., 1995; Cobben et al., 1995).  With respect to protein 
translation, previous studies aimed at identifying cellular components that initiate internal 
translation of rhinoviral RNA led to the discovery of a 38 kDa WD40 repeat protein 
complexed with UNR (Hunt et al., 1999), a cytoplasmic RNA-binding protein that has 
been implicated in the cap-independent translation of various proteins.  This protein, 
termed UNRIP (UNR- interacting protein), is an alias for STRAP.  Although STRAP did 
not appear to play a functional role in the initiation of viral translation, it has been 
reported that UNRIP/STRAP can function in concert with other cellular proteins to 
increase c-MYC translation in vitro through utilization of an internal ribosomal entry site 
(IRES) (Evans et al., 2003).  Because c-MYC is a recognized oncogene, it is possible 
that overexpression of STRAP can promote tumor growth by up-regulating c-MYC when 
the necessary translational cofactors are present. 
 
 
 16 
 
STRAP expression is associated with mesenchymal morphology in MEFs 
The epithelial-to-mesenchymal transition (EMT) refers to a process by which 
normal and neoplastic cells down-regulate expression of junctional epithelial markers 
and upregulate expression of mesenchymal genes.  EMT is often gauged by a 
morphological switch that suggests an increased capacity for cellular migration.  
Recently, it has been shown that STRAP knockout in mouse embryonic fibroblasts 
causes cells to adopt a metastable phenotype characterized by the expression of both 
mesenchymal and epithelial lineage markers, such as E-cadherin (Kashikar et al., 2010).  
Importantly, enforced expression of STRAP in knockout MEFs abrogated E-cadherin 
expression and restored the mesenchymal morphology to the fibroblasts (Kashikar et al., 
2010).  Although this study suggests that STRAP is involved in the specification of a 
mesenchymal cell fate, the relationship between morphology and motility remains to be 
determined.   
 
Clinical significance and targeted inhibition of STRAP 
 Preliminary studies suggest that STRAP overexpression may be relevant to the 
development of various cancers.  The up-regulation of STRAP has been reported in lung 
and colorectal tumor tissue samples analyzed by western blot and immunohistochemical 
staining (Matsuda et al., 2000, Halder et al., 2006).  In a much larger clinical study of 
colorectal cancer specimens, STRAP overexpression was detected in 70.7% of 
specimens analyzed (Kim et al., 2007).  Although there was no clinical evidence to 
suggest that STRAP was correlated with disease stage or survival in this study, it has 
been reported that STRAP amplification predicts disease outcome in response to 
chemotherapeutic regimens.  Specifically, colorectal cancer patients whose tumors 
contained increased STRAP copy numbers exhibited decreased overall survival when 
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adjuvant 5-Fluorouracil (5-FU) therapy was administered whereas patients without 
STRAP amplification benefited from 5-FU treatment (Buess et al., 2004).  It is not yet 
clear why STRAP copy number affects chemotherapeutic response and survival but it is 
important to note that amplification of other genes on chromosome 12p was not reported 
in this study.  Gains in chromosome regions proximal to the STRAP locus has been 
reported in teratomas and basal-like breast cancer so it's possible that amplification of 
nearby genes may also account for the observed differences in these patients 
(Henegariu et al., 1998; Poulos et al., 2006; Han et. al, 2008; Natrajan et al., 2009). 
  Further work will be needed to clarify the role of STRAP in carcinogenesis, but 
clinical data reported thus far indicate that there is a strong association between STRAP 
overexpression and cancer.  In vitro studies on the biological functions of STRAP 
suggest that it can modulate various oncogenic signaling pathways while in vivo animal 
studies indicate that STRAP expression promotes tumor formation (Halder et al., 2006).  
Taken together, it is likely that STRAP influences the pathways and processes that drive 
cancer progression and should not simply be regarded as a biomarker.  As such, 
STRAP may be relevant target for the development of anti-cancer therapeutics.  At the 
present time, there are no reports of any STRAP inhibitors in clinical use or 
development.  However, it has recently been shown that Pateamine A, a product of 
marine sponges, can bind to STRAP and the eukaryotic translation initiation factor eIF4A 
(Low et al., 2005; Low et al., 2007).  Although the effects of Pateamine A association 
with STRAP have not been characterized, Pateamine A and its analogs have already 
been shown to block eukaryotic translation (Low et al., 2007) and proliferation of cancer 
cells (Kuznetsov et al., 2009).   
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The c-JUN proto-oncogene 
 
 c-Jun, a  component of the activating protein-1 (AP-1) transcription factor, is 
recognized as an immediate early gene due to its rapid induction in response to various 
growth factors (Lamph et al., 1998).  c-Jun predominantly localizes to the nucleus and 
exhibits a high degree of conservation among chordates.  Structurally, the c-Jun protein 
contains multiple functional domains (Figure 5).  c-Jun contains two activation domains 
(AD) that facilitate transcription of AP-1 target genes and an N-terminal delta domain (δ), 
which interacts with the c-Jun activating protein, c-Jun N-terminal kinase (JNK).  At the 
C-terminus, c-Jun contains a DNA-binding domain (DBD) and a leucine zipper 
dimerization domain.  The viral counterpart to c-Jun, v-Jun, lacks the N-terminal δ 
domain which renders v-Jun expressing cells unresponsive to regulation by JNK.  In 
addition to the deletion of the δ domain, v-Jun contains many amino acid substitutions 
and deletions that promote v-Jun protein stability.   
 As a constituent of AP-1, c-Jun has been reported to heterodimerize with Fos, 
activating transcription factor (ATF), or the Jun dimerization protein (JDP) family of 
proteins.  Interestingly, c-Jun homodimers can also form low affinity DNA binding 
complexes (Ryseck and Bravo, 1991; Carrillo et al., 2009), although heterodimers are 
preferentially formed under physiological conditions (Carrillo et al., 2009).  Depending on 
the specific c-Jun binding partner, AP-1 can induce or inhibit expression of genes 
containing the TPA-DNA response element (TRE; 5'-TGAG/CTCA), accounting for the 
diverse biological effects of AP-1 signaling.   
  Among the best characterized AP-1 complexes is the c-Jun/c-Fos heterodimer.  
c-Jun/c-Fos has been shown to regulate cellular proliferation and survival through  
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transactivation of a wide array of genes including cyclin D1, KGF, HB-EGF and 
suppression of p53, p21CIP1, and p16INK4A (Shaulian and Karin, 2002).  Although c-Jun 
expression is important for normal cell growth, aberrant c-Jun activity has been 
implicated in oncogenesis (Zhang et al., 2007; Synder et al., 2009; Mishra et al., 2010).  
As such, c-Jun activity and expression are subject to stringent regulation through control 
of transcription, protein synthesis and post-translational modification.  Expression of c-
Jun is induced in the G1 phase of the cell cycle and undergoes rapid decline after entry 
into S phase (Rysek et al., 1988; Carter et al., 1991).  At the post-transcriptional level, it 
has been reported that c-Jun must be phosphorylated at S63 and S73 by JNK  in order 
to form transcriptionally active AP-1 heterodimers (Derijard et al, 1994; Minden et al., 
Figure 5.  Functional domains in c-Jun and v-Jun.  c-Jun, a component of the 
AP-1 transcription factor, is comprised of multiple functional domains.  The C-
terminus of c-Jun contains a DNA-binding domain (DBD) that directly interacts 
with DNA regions containing the TPA-response element.  The basic leuicine 
zipper (bZIP) domain mediates dimerization with FOS, ATF, or JDP proteins and 
facilitates interactions with DNA.  The activation domains (AD) in c-Jun are 
required for transcription of AP-1 target genes.  The delta (δ) domain recruits the 
serine/threonine kinase, JNK, which promotes AP-1 activity and c-Jun 
stabilization through phosphorylation of S63 and S73 in the N-terminus of c-Jun.  
The viral counterpart to c-Jun, v-Jun, contains many genetic alterations that 
confer oncogenic properties to the protein.  Loss of the δ domain renders v-Jun 
exempt from JNK-mediated activation.  Additional point mutations and interstitial 
deletions within the v-Jun coding sequence have also been reported to increase 
protein stability.   
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1994).  It has also been shown that MEK/ERK signaling promotes AP-1 activation 
indirectly through induction of c-Jun (Lopez-Bergami et al., 2007), but JNK-independent 
mechanisms for c-Jun activation were not reported.  However, a recent study by Davies 
et al. indicates that MEK1 stabilization of RING-domain containing protein-1 (RACO-1) 
promotes RACO-1 association with c-Jun and AP-1 activity independent of JNK-
mediated phosphorylation (Davies et al., 2010).  Taken together, these studies may 
suggest that deregulation of MAPK signaling pathways promotes tumorgenesis through 
convergence on AP-1 activitation.     
 
The ubiquitin proteasome and c-Jun stability 
In addition to regulation of c-Jun induction and activity, c-Jun expression is regulated 
through protein degradation.  Protein turnover in the cytosol and nucleus of most 
eukaryotic cells is regulated by a large multi-protein complex called the proteasome.   
Proteins targeted for destruction by the proteasome undergo a post-translational 
modification in which a small protein, ubiquitin, is covalenty attached to lysine residues 
within the substrate.  The process of ubiquitylation involves multiple steps, each 
executed by three separate enzymes (Figure 6).  First, a ubiquitin molecule is activated 
by an E1 ubiquitin-activating protein and transferred to an active site within the E1 in an 
ATP-dependent manner.   Next, the ubiquitin is transferred to an E2 ubiquitin 
conjugating enzyme.  The E3 ubiquitin ligase protein can then directly mediate transfer 
of the ubiquitin from the E2 to the substrate or functions as an intermediate, transferring 
the ubiquitin to itself before modifying the target protein.   
 Several studies have experimentally determined that the half-life of c-Jun is 
approximately 1.6 hours (Wei et al., 2005; Gao et al., 2006).  c-Jun protein stability can 
be directly regulated by multiple classes of proteins, including kinases, phosphatases, 
and ubiquitin E3 ligases (Table 1).  Phosphorylation of c-Jun by JNK at S63 and S73 has 
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been reported to increase the stability of c-Jun (Fuchs et al., 1994; Sabapathy et al., 
2004).  Calcineurin (CaN)-mediated dephosphorylation of c-Jun at S243 has also been 
reported to stabilize c-Jun (Huang et al., 2008).  Conversely, post-translational 
modification of other residues in c-Jun has been reported to destabilize c-Jun.  The 
COOH-terminal SRC kinase (CSK) promotes c-Jun degradation through phosphorylation 
of c-Jun at Y26 and Y170 (Zhu et al., 2006).  However, phosphorylation of Y170 by the  
tyrosine kinase c-ABL decreases ubiquitylation and degradation of c-Jun by inhibiting 
ITCH binding (Gao et al., 2006).  These conflicting reports may suggest that some E3 
ligases require phosphorylation of multiple residues within the target protein for substrate 
recognition and binding.  It has also been shown that glycogen synthase kinase 3-beta 
(GSK3β) -dependent phosphorylation of c-Jun at T242 is essential for F-box and WD 
repeat domain-containing 7 (FBW7) mediated ubiquitylation of c-Jun (Wei et al., 2005).  
In addition to the FBW7 and ITCH, both map kinase kinase 1 (MKK1) and the De-
etiolated-1 (DET1)/constitutively photomorphogenic 1 (COP1) complex have also been 
reported to exhibit E3 ligase activity towards c-Jun (Wertz et al., 2004; Xia et al., 2007).  
Although each ligase recognizes a unique sequence in c-Jun, the apparent redundancy 
in target selection underscores the importance of regulating c-Jun expression. 
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Figure 6.  The Ubiquitin-Proteasome Pathway (simplified).  Proteins that are marked for 
destruction by the 26S Proteasome are post-translationally modified through the covalent 
attachment of ubiquitin molecules.  The process of attachment involves three distinct steps 
in which a ubiquitin molecule is shuttled between a ubiquitin-activating protein (E1) and a 
ubiquitin-conjugating protein (E2) before a ubiquitin ligase (E3) mediates transfer of the 
ubiquitin molecule to a lysine residue within the target protein.  After attachment of one 
ubiquitin molecule, addition ubiquitins are attached to the preceding ubiquitin molecule to 
form a poly-ubiquitin chain.  The ubiquitylated substrate can then enter the proteasome 
where it undergoes degradation.   
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Table 1.  Regulators of c-Jun stability 
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Directed Migration 
 
 Directional migration is a complex process by which a cell migrates towards or 
away from a stimulus.  Thus far, different types of directed migration have been 
described.  Chemotaxis is a form of motility induced by a soluble chemical gradient 
whereas haptotaxis involves migration up a gradient of substratum-immobilized ligand.  
In adherent cell types, the process of directed migration has been divided into several 
distinct steps.  Initiation of cell motility involves actin-driven membrane protrusion at the 
leading edge and the formation of nascent attachments to the underlying matrix proteins 
(Sheetz et al., 1999).  Actin-myosin contractility and adhesion disassembly at the lagging 
edge of the cell facilitate forward movement by permitting retraction of the cell body and 
tail (Lauffenberger and Horowitz, 1996; Cheresh et al., 1999).  Furthermore, endocytic 
recycling of adhesion receptors from the back to the front of the cell support continued 
movement (Pierini et al, 2000).   
 At the molecular level, cell migration requires the coordinate activity of multiple 
signaling pathways including focal adhesion kinase (FAK), SRC, phosphoinositide-3 
kinase (PI3K), and the Rho GTPase family.  Importantly, activation of these signaling 
pathways are spatially restricted within the cell to permit the requisite polarization that 
generates the leading edge during motility.   
 
Regulators of gradient sensing and cell polarity 
 Cell polarization is a complex process whereby cells undergo changes to their 
cell shape through rearrangement of their actin cytoskeleton.  The process of 
polarization establishes a physical asymmetry with a defined leading and lagging edge.  
In addition to the morphology changes, polarized cells asymmetrically redistribute 
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phospholipid signaling molecules in order to recruit the actin polymerization machinery to 
the leading edge.   
 Studies on the social amoebae, Dictyostelium discoideum, and neutrophils have 
significantly informed our current understanding of the mechanisms regulating both 
gradient sensing and polarization.  In the presence of a chemoattractant, Dictyostelium 
becomes polarized with a pseudopod extending in the direction of the highest 
concentration of gradient.  Dictyostelium also exhibit the capacity to reorient in response 
to changes in the position of the gradient.  The "local excitation-global inhibition" model 
of gradient sensing suggests that local changes in G-protein coupled receptor (GPCR) 
ligand occupancy provide the upstream signal that regulates directionality of movement 
(Parent and Devreotes, 1999) (Figure 7A).  In Dictyostelium and mammalian cells, 
GPCRs are uniformly distributed around the cell perimeter.  In the absence of a stimulus, 
there is limited steady-state activation of GPCRs.  Fluorescence resonance energy 
transfer (FRET) analysis of GPCR α and βγ binding has shown comparable levels of 
bound and unbound complexes in Dictyostelium before exposure to cyclic AMP (cAMP) 
(Xu et al., 2005).  However, application of a cAMP gradient leads to increased activation 
of receptors on the side of the cell facing the gradient source, thus generating the 
localized excitatory signal that initiates downstream cellular events, including polarization 
and directed migration (Xu et al., 2005).   
  GPCR activation has been reported to promote cell polarization through Ras- 
mediated activation of PI3K signaling (Li et al., 2000; Funamoto et al., 2001, Funamoto 
et al., 2002).  At the leading edge, PI3K converts the membrane phospholipid PIP2 to 
PIP3, which induces actin cytoskeleton remodeling through activation of AKT-
RAC/CDC42 signaling.  In both Dictyostelium and neutrophils, PI3K has been reported 
to localize to the leading edge of polarized cells, whereas PTEN is distributed along the 
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lateral and posterior axes of the cells (Funamoto et al., 2002) (Figure 7B).  PI3K 
recruitment to the membrane occurs through direct interaction with the p101 non-
catalytic subunit of Gβγ (Brock et al., 2002).   
 Recruitment of AKT to the leading edge is not dependent on polarization as 
inhibition of actin polymerization does not prevent AKT membrane localization (Servant 
et al., 2000).  However, PIP3/AKT signaling is dependent on GPCR signaling as 
inhibition of G-proteins with pertussis toxin abrogates AKT-PH membrane recruitment 
(Servant et al., 2000).  These studies suggest that the redistribution of phospholipid 
signaling proteins is an intermediate step between GPCR activation and cell polarization.  
However, some studies suggest that the requirement of PI3K for chemotaxis is not 
absolute.  The PI3K 1/2/3 triple knockout Dictyostelium are less polarized but can 
migrate with a reduced speed towards steep gradients of cAMP (Takeda et al., 2007).  
Furthermore, engulfment of cell motility engulfment of cell motility (ELMO)-dedicator of 
cytokinesis (DOCK) mediated activation of RAC can promote cell polarization and 
chemotaxis of HL-60 cells following PI3K inhibition in vitro (Sai et al., 2008).  
Interestingly, neutrophil migration to laser-induced wounds in zebrafish is PI3Kγ- 
dependent as activation of RAC is insufficient to rescue the anterior polarization and 
motility defects observed in these cells (Yoo et al., 2010).  This study may suggest that 
PI3K-induced AKT recruitment is necessary for proper cell polarization and chemotaxis  
in vivo but further work will be needed to address the discrepancies observed in different 
model systems and cell types.   
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Figure 7.  Mechanisms regulating gradient sensing and cell polarization.  A.  
Gradient sensing in eukaryotes is dependent on localized activation of G protein-
coupled receptors.  Application of a gradient increases receptor occupancy on the 
side of the cell closest to the gradient source, leading to localized signal transduction 
events proximal to the activated GPCRs.  This spatially restricted signaling initiates an 
asymmetric redistribution of proteins within the cell such that regulators of cell 
polarization and actin polymerization are concentrated at sites of GPCR activation.  B.  
Polarized cells are characterized by the asymmetric distribution of signaling 
molecules.  GPCR activation promotes PI3K recruitment to the leading edge through 
direct interaction with the Gβγ subunit.   PI3K subsequently converts the PIP2 
phospholipid to PIP3, which recruits AKT to the leading edge by associating with the 
AKT pleckstrin homology domain.  PTEN phosphatase is spatially restricted to the 
lateral sides and lagging edge of polarized cells to inhibit dephosphorylation of 
PIP3.  AKT induces membrane protrusions at the leading edge by activating the actin 
cytoskeleton remodeling proteins, RAC1 and CDC42.   
 28 
 
Cell adhesion and motility 
 Cell adhesion to extracellular matrix proteins is regulated by a large multi-protein 
complex that anchors the actin cytoskeleton to the underlying substratum.  Nascent 
attachments to the ECM are generally referred to as focal complexes.  In migrating cells, 
focal complexes are formed at the edges of the lamellapodia and have been reported to 
contain integrins, talin, vinculin, FAK, tensin, and α-actinin (Laukaitis et al., 2001; Zaidel-
Bar et al., 2003).  The resident integrin receptor, comprised of a pairing between various 
alpha and beta subunits, varies according to the protein composition of the matrix (Table 
2).  These focal complexes either disassemble or undergo a  maturation process 
involving the incorporation of additional proteins to form focal adhesions (Zaidel-Bar et 
al., 2003) (Figure 8A).   
 Proteomic analysis of purified focal adhesions has recently identified over 900 
different focal adhesion proteins (Kuo et al., 2011).  Although protein-protein interactions 
within the focal adhesion have been identified for some proteins (Figure 8B), the 
complex network comprising the focal adhesion interactome and the signaling modules 
within the adhesions have yet to be fully realized.  Early investigators discovered that 
focal adhesion formation occurs through bidirectional "signaling" through integrin 
receptors.  Integrin binding to ECM enables cells to remodel their actin cytoskeleton in 
response to mechanical cues from the underlying matrix.  The mechano-transduction 
represents "outside-in" signaling and can cause adaptive response due to changes in 
substratum rigidity.  Conversely, talin association with the integrin cytoplasmic tail 
promotes "inside-out" signaling by inducing a conformational switch in the integrin 
receptor that renders the integrin permissive for ligand binding (Anthis et al., 2009).  
Apart from integrin activation, talin directly associates with the adaptor protein vinculin, 
which functionally links the focal adhesion to the actin cytoskeleton (Humphries et al., 
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 β subunit α subunit Ligand 
β1 α1 collagen 
β1 α2 collagen 
β1 α3 laminin 
β1 α4 fibronectin 
β1 α5 fibronectin 
β1 α6 laminin 
β1 α7 laminin 
β1 α8 fibronectin, vitronectin 
β1 α9 tenascin-C 
β1 α10 collagen 
β1 α11 collagen 
β1 αv fibronectin, vitronectin 
β3 αII fibrinogen, fibronectin 
β3 αv vitronectin, fibronectin 
β4 α6 laminin 
β5 αv vitronectin 
β6 αv fibronectin 
β8 αv vitronectin 
β2 & β7 =leukocyte specific  
 Adapted from Cell Tiss Res (2010) 339, 267-80 
 
 
 
  
Table 2.  Integrin pairings and cognate ligands 
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Figure 8.  Focal adhesion architecture and interactome (simplified).  A.  Focal 
adhesion complexes are formed at sites of integrin binding to extracellular matrix.  
Active integrin receptors recruit FAK through direct association with talin and paxillin.  
Autophosphorylation of FAK leads to SRC recruitment and full activation of FAK.  
FAK/SRC signaling regulates focal adhesion dynamics and membrane protrusions 
through phosphorylation of a wide array of effector proteins.  B.  Interactome map of 
focal adhesion components.  Stable components within focal adhesions are 
contained within the shaded green box while non-resident modulators of focal 
adhesion proteins are placed outside the box.   
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Figure 8.  Focal adhesion architecture and interactome (simplified). 
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2007).  Vinculin has also been reported to bind paxillin (Wood et al., 1994), which 
supports focal adhesion growth through recruitment of actin-binding proteins  and 
various enzymes (Schaller, 2001).  The tyrosine kinase, FAK, is recruited to cell-matrix 
adhesions  through association with paxillin (Hildebrand et al., 1995; Tachibana et al., 
1995; Hayashi et al., 2002) and talin (Chen et al., 1995).  FAK then promotes focal 
adhesion  enlargement by recruiting additional proteins such as SRC and p130Cas to  
the focal adhesion complex to generate the central signaling module of focal adhesions.  
Taken together, these studies highlight the complex interactions that support focal 
adhesion assembly.  These interactions generate a stable link between the integrin-ECM 
complex and the actin cytoskeleton, and serve as a large signaling conduit that allows 
cells to respond to mechanical and chemical stimuli in the extracellular environment 
 
Focal adhesion kinase signaling pathways 
 FAK is a cytoplasmic protein tyrosine kinase that mediates cell adhesion and cell 
motility through activation of actin cytoskeleton remodeling proteins. FAK enzymatic 
activity and interactions with its various effectors are modulated through phosphorylation 
of key residues within FAK as well as through discrete functional domains within FAK 
(Figure 9) (Mitra et al., 2005).  After recruitment to the focal complexes, activation of 
FAK is initiated by autophophorylation of Y397, which creates a docking site for c-SRC 
(Schaller et al., 1994).  SRC fully activates FAK through phosphorylation of Y596, Y597, 
Y861, and Y925 residues (Mitra et al., 2005).   
 The biological significance of FAK signaling was initially gleened from in vitro 
studies using fibroblasts isolated from FAK knockout embryos.  Loss of FAK expression 
caused fibroblasts to adopt a round morphology characterized by an increased number 
of small focal adhesions and decreased haptotaxis towards fibronectin (LLić et al., 
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1995).  Reintroduction of full length FAK rescued the morphology and motility defects in 
fibroblasts (Sieg et al, 1999), supporting the initial finding that FAK signaling promotes 
motility.  The FAK-related kinase, protein tyrosine kinase 2 (PYK2), exhibits >60% 
sequence homology to FAK and is predicted to contain identical functional domains 
(Figure 9).  However, endogenous PYK2 does not localize to focal adhesions (Sieg et 
al., 1998).  As such, overexpression of PYK2 fails to rescue the motility defect in FAK -/- 
fibroblasts (Sieg et al., 1998), whereas a PYK2 chimera containing the FAK C-terminal 
FAT domain rescues both the fibroblastoid morphology and haptotaxis defect (Klingbeil 
et al., 2001).  Collectively, these studies suggest that FAK signaling within the focal 
adhesion complex is necessary for motility.     
 The effects of FAK on cell adhesion, spreading, and motility are achieved 
through its interactions with a wide array of effector proteins.  FAK recruitment and 
phosphorylation of p130Cas promotes membrane protrusions and motility through 
downstream activation of Rac1.  In addition to p130CAS, FAK has been reported to 
promote Rac1-mediated cell spreading through activation of the RAC/CDC guanine 
nucleotide exchange factor (GEF), βPIX (Chang et al., 2007).  Previous studies suggest 
that FAK promotes actin related protein 2/3 (ARP 2/3) activation and membrane 
protrusions through phosphorylation-dependent regulation of neuronal Wiskott-Aldrich 
syndrome protein (N-WASP) subcellular localization (Wu et al., 2004).  Interestingly, 
FAK has also been reported to promote cell spreading by direct association with ARP3 
during the early phases of cell attachment to fibronectin (Serrels et al., 2007).  FAK 
mediated inhibition of RhoA has been reported to promote focal adhesion formation and 
cell spreading (Ren et al., 2000).  Subsequently, it was shown that FAK forms a complex 
with p120Ras GTPase-activating protein (GAP) and p190RhoGAP and that 
p190RhoGAP localization to membrane protrusions was dependent on FAK expression 
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in MEFs (Tomar et al., 2009).  These findings suggest that leading edge ruffling and cell 
polarization are achieved through FAK-mediated RhoA inhibition in membrane  
 
 
 
 
 
 
 
 
 
 
 
 
 In addition to regulation of focal adhesion assembly and membrane protrusion, 
FAK-SRC signaling has also been reported to regulate focal adhesion disassembly.  
 
Figure 9.  Comparison of FAK and PYK2 functional domains.  FAK and the 
related PYK2 kinase share similar functional domains but are not functionally 
redundant.  The FAK FERM domain mediates interactions with PDGFR, EGFR, 
Ezrin, and ETK while the PYK2 FERM promotes self oligomerization and binding to 
NIR proteins (Lipinski and Loftus, 2010).  The kinase domains of FAK and PYK2 
exhibit the greatest degree of sequence identity.  Activation of FAK and PYK2 
depends on recruitment of the Src family of protein kinases to phospho-tyrosine 
residues within the FAK and PYK2 kinase domains (Y397 and Y402, respectively).  
The Src kinases phosphorylate key tyrosine residues within both proteins (Y576, 
Y577, Y861, and Y925 of FAK vs. Y579, Y580, and Y881 of PYK2).  The proline-rich 
regions (PPRs) of FAK and PYK2 mediate binding with p130Cas, ASAP1, and 
GRAF.  The FAT domain of FAK associates with GRB2, p190RhoGEF, talin, and 
paxillin.  The FAK FAT domain is required for FAK targeting to focal adhesion 
complexes.  The FAT domain of PYK2 has also been reported to promote protein 
interactions with GRB2 and paxillin but does not direct PYK2 localization to focal 
adhesions.  PYK2 is primarily concentrated in the perinuclear region of cells.   
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Loss of FAK and SRC expression significantly slow the rate of focal adhesion turnover 
(Webb et al., 2004).  Disassembly of focal adhesions is dependent on the activation of 
FAK as mutation of the FAK autophosphorylation site, inhibits adhesion turnover 
(Hamadi et al., 2005).  Chemical inhibition or mutation of phospho-acceptor sites within 
the FAK targets, ERK and paxillin, inhibited focal adhesion disassembly (Webb et al., 
2004).  Furthermore, mutation of SRC phosphorylation sites on FAK has also been 
reported to inhibit adhesion turnover by disrupting complex formation between FAK, 
ERK, and calpain 2 (Westhoff et al., 2004).  As calpains have been implicated in 
adhesion turnover through cleavage of focal adhesion components such as FAK and 
talin (Carragher et al., 1999; Westhoff et al., 2004), recruitment of calpains by FAK to the 
focal adhesion suggests that FAK-SRC scaffolding functions also regulates adhesion 
dynamics. 
 
Summary and Aims 
Based on the literature published thus far, it appears that many of STRAP's 
signal transduction activities are context-dependent as the specific protein-protein 
interactions are dependent on agonist treatment.  Furthermore, STRAP's binding 
partners have also been reported to bind to each other, which may indicate that there is 
considerable and complex cross-talk between the signaling pathways regulated by 
STRAP.  Much of the literature on STRAP has been published in recent years so it is 
likely that many novel interactions and biological roles for STRAP will continue to be 
discovered.   
 In consideration of the biological functions of STRAP, it's becoming increasingly 
apparent that deregulation of STRAP expression can contribute to the development of 
cancer through activation of mitogenic and survival signaling pathways.  Furthermore, 
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the role of STRAP in cell morphology determination and MMP28 transcription suggests 
that STRAP may also be involved in EMT and tumor metastasis.  The overall aim of this 
dissertation work was to further explore the oncogenic characteristics of STRAP.  
Immortalized fibroblasts isolated from wild type and STRAP knockout embryos were 
selected as a model system for these studies in order to mitigate the confounding effects 
associated with incomplete or off-target gene knockdown by RNA interference.  Although 
the majority of cancers arise from epithelial cells, STRAP has been reported to regulate 
ERK and TGF-β/SMAD signaling in both fibroblasts and epithelial cells (Halder et al., 
2006; Datta and Moses, 2000), suggesting that the effects of STRAP on oncogenic 
signaling pathways may affect parallel processes in different cell types.  Furthermore, 
stromal fibroblasts have been shown to promote epithelial tumor progression by affecting 
tumor growth, vascularization, and metastasis (Kalluri and Zeisberg, 2006).  As such, 
STRAP signaling in fibroblasts may provide useful insights into how stromal fibroblasts 
affect epithelial-derived cancers.   
 Herein, I present data on the role of STRAP in mitogenic signaling and cellular 
motility.  In the second chapter, I will show that STRAP inhibits ubiquitin-mediated 
proteolysis of the c-Jun proto-oncogene and promotes cell autonomous growth of 
fibroblasts.  In the third chapter, I provide evidence that STRAP expression is required 
for persistent migration in serum gradients and uropod retraction during chemotaxis.  
The significance of this work in the broad context of cancer and the role of fibroblasts in 
cancer are discussed in the last chapter.   
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Chapter II 
 
STRAP STABILIZES c-JUN AND PROMOTES CELLULAR PROLIFERATION 
 
Introduction 
 There is growing evidence to suggest that STRAP over-expression exerts a 
largely tumorigenic effect on cells. STRAP over-expression has been detected in human 
lung, colon, and breast cancer (Matsuda et al., 2000; Halder et al., 2006).  Furthermore, 
STRAP expression promotes anchorage-independent growth of various cell lines in vitro 
as well as tumor formation in nude mice (Halder et al., 2006).   At the cellular level, 
STRAP over-expression may support tumor growth through inhibition of TGF-β-induced 
growth inhibition.  However, STRAP overexpression has been correlated with ERK 
activation and pRb phosphorylation in the absence of exogenous TGF-β (Matsuda et al., 
2000; Halder et al., 2006).   
 In light of the well known mitogenic and oncogenic effects of ERK activation, it is 
plausible that overexpression of STRAP can drive proliferation of neoplastic cells.  In 
some experimental contexts, activation of ERK has been shown to promote S phase 
entry through induction of cyclin D1 (Zhang et al., 1999; Teixeira et al., 2000).  Cyclin D1 
associates with cyclin-dependent kinase 4/6 (CDK 4/6) to form a functional enzymatic 
complex that directly phosphorylates the tumor suppressor protein, pRb.  Hyper-
phosphorylation of pRb then promotes dissociation from the E2F transcription factor, 
which translocates to the nucleus and induces expression of genes required for cell 
cycle progression.  However, pRb phosphorylation may not be dependent on ERK 
activation as previous studies have shown that activation of the p38 and JNK MAPK 
pathways can also induce cyclin D1 expression (Papassava et al., 2004; Slisz et al., 
 38 
 
2008).  As such, we hypothesized that STRAP regulates signaling by affecting 
components of the MAPK signaling pathways.  Here, we will show that STRAP 
expression promotes c-Jun activation and expression in fibroblasts by inhibiting c-Jun 
ubiquitylation and degradation.  The increased stability of c-Jun is correlated with 
increased expression of the AP-1 target gene, cyclin D1, and increased proliferation.  
These findings may suggest a novel mechanism by which STRAP can promote 
tumorigenesis by stimulating cell autonomous growth.   
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Materials and methods 
 
Cell lines and plasmids 
Immortalized STRAP knockout and wild type fibroblasts were generously donated by Dr. 
Philippe Soriano (Mount Sinai Medical Center, New York, NY).  MEFs and 293T cultures 
were maintained in DMEM supplemented with 7% FBS.  pcDNA3-c-Jun was kindly 
provided by Dr. Mike Engel (Vanderbilt University, Nashville, TN).  The His6-Ubiquitin 
expression construct was a gift from Dr. Christoph Eglert (Leibniz Institute for Age 
Research, Jena, Germany).  Construction of the pcDNA3.1-STRAP-HA and pBABE 
puro-STRAP-HA expression vectors has been described elsewhere (Datta et al., 1998).   
 
Reagents and antibodies   
MG132, cyclohexamide, and sodium butyrate were purchased from Sigma (St. Louis, 
MO).  Lithium chloride was obtained from Calbiochem (La Jolla, CA).  The STRAP 
monoclonal antibody was purchased from BD Transduction Labs (San Jose, CA).  
PARP, c-Jun, cyclin D1, p53, and JNK antibodies were from Santa Cruz Biotechnology 
(Santa Cruz, CA).  The phospho c-Jun, JNK/SAPK, c-fos, and FosB antibodies were 
from Cell Signaling Technology (Beverly, MA).  The cleaved caspase 3 antibody was 
purchased from Trevigen, Inc (Gaithersburg, MD).  The c-myc custom antibody was 
provided by Dr. Steve Hann (Vanderbilt University, Nashville, TN).   
 
Generation of stable cell lines 
For the preparation of retroviral particles, 2.5 x 106 Phoenix cells were seeded into 10 cm 
tissue culture dishes.  The following day, the cultures were transfected with 10 µgs of 
pBABE puro control vector or pBABE puro-STRAP-HA vector using lipofectamine LTX.  
 40 
 
Forty eight hours post-transfection, the viral supernatant was centrifuged at 1,000 rpm 
and passed through a .45 µM syringe filter.  The clarified virus was then pipetted onto 
early passage STRAP null fibroblasts.  Approximately fifteen hours later, the viral 
supernatant was aspirated off the cells and the cells were fed with DMEM containing 
10% serum.  The following day, the cultures were selected with 0.75 µg/ml of puromycin 
to isolate polyclonal vector control and STRAP-HA-expressing cultures.   
 
Western blot analysis 
For terminal experiments requiring treatments, 10 mM sodium butyrate (24 hours), 10 
mM LiCl (16 hours) and 50 μM MG132 (4 hours) was added directly to the growth 
medium before cell lysis.  Subconfluent cultures were incubated in mammalian lysis 
buffer [50 mM Tris–HCl [pH 7.5], 150 mM NaCl, 10 mM EDTA, 0.5% Nonidet P-40, 0.5 
mM dithiothreitol, 5 mM sodium fluoride, 0.5 mM sodium orthovanadate, 1.0 mM 
phenylmethylsulfonyl fluoride, 3 μg/ml each of leupeptin, pepstatin, and aprotinin] for 15 
minutes on ice.  The cells were then scraped, sonicated, and centrifuged at 13,000 rpm 
for 15 minutes at 4°C.  The protein concentration of the clarified lysates was measured 
using Bradford reagent (Bio-Rad, Hercules, CA).  Equal concentrations of protein 
extracts were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and 
transferred to polyvinylidene fluoride (PVDF) membranes (Bio-Rad, Hercules, CA).  The 
membranes were then immunoblotted with the indicated antibodies.  Quantitation of 
protein bands was performed using NIH Image J software.  The relative densities for 
each sample were calculated by normalizing against the corresponding actin densities. 
The average relative density from at least three independent experiments is shown.    
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Cell growth Assays 
For the cell counting assays, 3 x 103 cells were seeded in triplicate wells of 12-well 
plates.  Forty eight hours after seeding, cells were trypsinized daily and counted in a 
hemocytometer.  The total number of cells was calculated for each well.  Results are 
expressed as the log of the total cell number + SEM for six independent experiments.  
For the thymidine incorporation assays, 2 x 104 cells were seeded in triplicate wells of 
12-well plates.  After 44 hours, the cultures were labeled with 4 μCi of [3H]-thymidine 
(NEN, Boston, MA) for two hours at 37○C.  The cells were fixed with an ice cold 10% 
trichloroacetic acid solution for 30 minutes and washed with the same solution two times 
for ten minutes.   The fixed cultures were then lysed in 300 μl of 0.2 N NaOH.  One 
hundred microliters of the lysate was added to four milliliters of scintillation fluid and the 
incorporated [3H]-thymidine was measured in a scintillation counter.  Results are 
expressed as the log of the counts per minute (CPM)  + SEM for six independent 
experiments.  Statistical analyses of cell counting and thymidine incorporation assays 
were performed using mixed-model ANOVA.     
 
Reverse transcription-PCR 
Total RNA was extracted from sub-confluent MEF cultures using TRIzol reagent.  Two 
micrograms of total RNA was reverse transcribed at 37°C for one hour using Moloney 
murine leukemia virus reverse transcriptase (Promega, Madison, WI).  Two microliters of 
the resulting cDNA was PCR amplified for 25 cycles using primers specific for c-Jun and 
glyceraldehyde-3-phosphate (GAPDH).  The PCR reaction was carried out using the 
following conditions:  denaturation at 95°C for one minute, annealing at 54°C for one 
minute, and elongation at 72°C for one minute. The specific primer sequences are as 
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follows: c-Jun 5’-GACTGCAAAGATGGAAACGA and 5’-GGGTTGAAGTTGCTGAGGTT; 
GAPDH  5'-ACCACAGTCCATGCCATCAC, and 5'-TCCACCACCCTGTTGCTGTA.   
 
Cycloheximide assays 
Sub-confluent wild type and STRAP knockout fibroblasts were treated with 100 µg/ml of 
cyclohexamide diluted in DMEM containing 7% serum.  The cultures were harvested at 
0, 0.5, 1, 2, and 4 hours after treatment.  The cells were lysed in mammalian lysis buffer 
and c-jun expression was determined by immunoblot analysis.   
 
Ubiquitylation assay.  293T cells were transiently transfected with c-Jun, His6-
Ubiquitin, and STRAP-HA expression plasmids using lipofectamine 2000 (Invitrogen, 
Calsbad, CA).  Empty pcDNA3 vector was used as a filler to ensure that each culture 
was transfected with an equal concentration of DNA.  Two days post-transfection, the 
cells were collected by scraping and washed with PBS.  One tenth of the cell suspension 
was boiled in 5X Laemmli buffer for immunoblot analysis of protein expression.  The 
remaining cell suspension was lysed in Buffer A pH 8.0 (6 M guanidine hydrochloride, 
0.1M Na2HPO4/NaH2PO4, 10 mM imidazole).   Ubiquitylated proteins were pulled down 
from the lysates with Ni-NTA resin for three hours at 4:C and washed two times in Buffer 
A.   The beads were then washed two times in Buffer A/T1 pH 6.8 (6 M guanidine 
hydrochloride, 0.1M Na2HPO4/NaH2PO4, 25 mM Tris-Cl, 15 mM imidazole) followed by 
one wash in Buffer T1 pH 6.8 (25 mM Tris-Cl, 20 mM imidazole).  The bound proteins 
were eluted by boiling in 3X Laemmli buffer containing 350 mM imidazole.  Equal 
volumes of eluate and whole cell extract were separated by SDS-PAGE and electro-
blotted onto PVDF membranes.  Ubiquitylated c-Jun was detected by immunoblot 
analysis. 
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Results 
 
STRAP regulates c-Jun protein expression and activation 
 In order to examine the role of STRAP in the regulation of MAPK signaling, the 
kinetics of p38 MAPK, ERK, and c-Jun activation was assessed in serum re-stimulated 
wild type and STRAP knockout cultures.  STRAP expression was not associated with 
increased ERK or p38 MAPK activation after the addition of serum (Figure 10A).  
However, serum induced c-Jun phosphorylation in wild type MEFs (Figure 10B).  
Activated c-Jun has been reported to positively auto-regulate its expression through 
binding to AP-1 sites on its own promoter (Angel et al., 1988).  Given that c-Jun 
activation levels peak more rapidly than c-Jun total protein for both cultures, it is possible 
that the phosphorylated protein is promoting c-Jun transcription.  The activation and 
expression of c-Jun was also examined in asynchronous cultures without re-stimulation.  
STRAP knockout significantly diminished c-Jun phosphorylation and expression, 
supporting our finding that STRAP regulates c-Jun activation and expression (Figure 
10C).   
 Activated c-Jun promotes cell cycle progression by transcriptionally regulating 
genes that are necessary for the G1 to S transition, including many growth factors and 
cyclin D1.  In accordance with the reduced phospho-c-Jun levels,  STRAP deletion 
decreased cyclin D1 expresion by western blot (Figure 10D) as well as cyclin D1 mRNA 
levels in a microarray study (unpublished data) .  To determine whether STRAP 
generally upregulates expression of other transcription factors, MEF lysates were 
immunoblotted for p53, c-Myc, c-Fos, and FosB (Figure 11).  p53 expression was used 
as positive control as STRAP has previously been shown to stabilize p53 through direct 
association (Jung et al., 2007).  As expected, p53 expression was significantly reduced  
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Figure 10.  STRAP expression correlates with increased activation and expression of 
c-Jun.  A.  Serum-starved wild type and STRAP null fibroblasts were stimulated with 10% 
FBS for the indicated times and immunoblotted for the expression of phospho-p38 MAPK, 
p38 MAPK, phospho-ERK, and ERK expression.  Loss of STRAP expression in MEFs 
increased p38 MAPK and ERK phosphorylation in response to serum.   Protein densities 
were normalized against actin and the mean density from three independent experiments 
is shown.  B.  Wild type and STRAP knockout MEFs were stimulated with serum after 
overnight serum withdrawal.   Protein lysates were prepared at various times post-
treatment with 10% serum.  Wild type MEFs exhibited increased phosphorylation and 
activation of c-Jun in response to serum.  The mean relative phospho-c-Jun and total c-Jun 
densities are shown.  C.  Phospho-c-Jun and total c-Jun expression was detected by 
western blot analysis of lysates prepared from wild type and STRAP null MEFs in 
logarithmic growth phase.  Wild type MEFs have increased levels of phosphorylated and 
total c-Jun protein.  The mean relative densities from three independent experiments are 
shown.  D.  Immunoblot analysis of the AP-1 target gene, cyclin D1, in wild type and 
STRAP null MEFs.  Cyclin D1 is down-regulated in STRAP knockout MEFs. The mean 
relative density of cyclin D1 from three independent experiments is shown.    
Reprinted from Biochem Biophys Res Comm (2011) 407, 372-7 with permission from Elsevier 
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Figure 11.  Effects of STRAP on the expression of various transcription factors.   
Sub-confluent wild type and STRAP knockout MEFs were immunoblotted with the indicated 
antibodies.  The density of the individual transcription factors was normalized to actin and 
the mean relative densities from at least four experiments are shown.  Statistical 
significance was determined with the Student's t-test.  Transcription factors that exhibit 
significant differences (p<0.05) between the means are denoted with an asterisk (*) 
 
Reprinted from Biochem Biophys Res Comm (2011) 407, 372-7 with permission from Elsevier 
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in STRAP null fibroblasts (p<0.05).  However, c-Myc was significantly up-regulated in the 
STRAP knockout cultures.  No significant differences in c-Fos, FosB, or FosB2 
expression were detected between wild type and STRAP knockout MEFs.  These 
findings suggest that STRAP exhibits specificity towards c-Jun rather than 
indiscriminately up-regulating the expression of all transcription factors.   
 
STRAP does not regulate c-Jun mRNA or JNK activation 
 Expression of c-Jun can be regulated by transcription, post-transcriptional 
modification, and degradation.  In order to determine whether STRAP transcriptionally 
regulates c-Jun expression, we examined c-Jun mRNA levels by RT-PCR (Figure 12A).  
No apparent differences in steady state c-Jun mRNA were detected, suggesting that 
STRAP does not affect transactivation or degradation of c-Jun mRNA.  To determine 
whether STRAP can promote c-Jun activation and expression through regulation of JNK 
activity, the kinetics of JNK activation in response to serum stimulation were examined in 
wild type and STRAP null MEFs.  Western blot analysis revealed marginal differences in 
the relative amounts of phosphorylated JNK and total JNK between wild type and 
STRAP MEFs (Figure 12B).  The ratio of phospho-JNK to total JNK was slightly higher in 
STRAP null MEFs (Figure 12C).  However, the ratio of phosphorylated to total protein 
may not an appropriate metric for determining JNK activity since the biological outcome 
is likely to depend on the active fraction rather than total protein pool.  The normalized 
p-JNK/ACTIN levels were not statistically significant by ANOVA suggesting that STRAP 
does not promote c-Jun expression through activation of JNK (Figure 12D).   
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Figure 12.  STRAP does not regulate c-Jun mRNA levels or JNK activation.  A.  RT-
PCR analysis of c-Jun mRNA levels in wild type and STRAP null MEFs.  The c-Jun mRNA 
was normalized against GAPDH.  The mean relative density from three independent 
experiments is shown.  B.  Wild type MEFs were serum-starved and re-stimulated with 
10% serum for the indicated time points.  “NA” samples represent cultures in normal log 
growth phase.  The lysates were immunoblotted for phospho-JNK and total JNK (top).  p-
JNK and JNK were normalized against actin and the mean densities from four independent 
experiments are shown.  C.  The ratio of the mean phospho-JNK density to the mean total 
JNK density from four independent experiments is shown.  D.  Graph of the mean relative 
density + SEM of p-JNK/Actin.   
  
Reprinted from Biochem Biophys Res Comm (2011) 407, 372-7 with permission from Elsevier 
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STRAP inhibits ubiquitin-mediated proteolysis of c-Jun 
In order to determine whether c-Jun expression levels in MEFs are regulated 
through proteasomal degradation, wild type and STRAP null MEFs were treated with the 
proteasome inhibitor, MG132, and the GSK3β inhibitor, LiCl.   As shown in Figure 13A 
(left), 50 µM MG132 treatment markedly increased Jun expression in both wild type and  
STRAP null MEFs, suggesting that proteasomal degradation modulates c-Jun protein  
levels in these cells.  The mean relative density + SEM from three independent  
experiments was plotted to show the considerable differences between the untreated 
and MG132 treated cultures (Figure 13A, right).  Interestingly, c-Jun protein levels in wild 
type and STRAP knockout MEFs were unaffected by treatment with 10 mM LiCl (Figure 
13A) or another GSK3β inhibitor, SB415286 (unpublished data).  These findings suggest 
that GSK3β/Fbw7 mediated degradation of c-Jun may not be necessary for c-Jun 
turnover in MEFs.  Next, we tested the effect of STRAP on c-Jun ubiquitylation in 293T 
cells (Figure 13B, left).  Co-expression of c-Jun and His-Ubiquitin produced a ladder 
comprised of mono- and poly-ubiquitylated Jun protein.  Over-expression of STRAP 
markedly decreased the ubiquitylation of c-Jun.  Importantly, western blot analysis of the 
corresponding lysates showed approximately equal amounts of poly-ubiquitylated 
proteins (unpublished data), indicating that STRAP expression does not result in a global 
decrease in ubiquitylation.  Mann Whitney analysis of fourteen independent experiments 
indicated that the effect of STRAP on c-Jun ubiquitylation is statistically significant, 
p<0.05 (Figure 13B, right).   
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Figure 13.  STRAP stabilizes c-Jun by inhibiting ubiquitin-mediated 
proteolysis of c-Jun.   A.  Wild type and STRAP null fibroblasts were treated with 
MG132 and LiCl.  The effect of treatment on total c-Jun protein levels was analyzed 
by immunoblot analysis.  Total c-Jun levels were normalized to actin and the mean 
relative densities from three independent experiments are shown (left).  The mean 
relative densities + SEM for each treatment were plotted (right).  B.  The 
ubiquitylation of c-Jun in the presence and absence of STRAP expression was 
assessed by transiently transfecting 293T cells with the indicated expression 
constructs.  Ubiquitylated proteins were pulled down from cell lysates using Ni2+-
NTA resin and analyzed for c-Jun by immunoblot analysis.  The relative expression 
of c-Jun and STRAP was determined by immunoblot analysis of whole cell extracts 
(left).  Ubiquitylated c-Jun was normalized to total Jun levels in the whole cell 
extracts.  The mean relative density + SEM of ubiquitylated c-Jun from 14 
experiments is shown.  Statistical significance was determined using the Mann 
Whitney test (right).   
 
Reprinted from Biochem Biophys Res Comm (2011) 407, 372-7 with permission from Elsevier 
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STRAP prolongs the half-life of c-Jun 
 In order to determine whether STRAP expression affects the half-life of c-Jun, 
wild type and STRAP null MEFs were treated with cycloheximide and the kinetics of  
c-Jun degradation were examined by western blot analysis (Figure 14A, left).  In STRAP 
knockout MEFs, c-Jun protein levels experienced a sustained and rapid decline over the 
four hour time course.  However, c-Jun levels in wild type appeared to gradually decline 
and stabilize at four hours, suggesting that STRAP inhibits c-Jun degradation.  The 
relative densities of c-Jun at various time points after cycloheximide addition were  
normalized to the initial density of c-Jun and plotted to show the approximate rate of c-
Jun decay (Figure 14A, right). Based on nonlinear regression analysis, the half-life of c-  
Jun in STRAP null fibroblasts can be estimated at one hour.  While the half-life of c-Jun 
in wild type MEFs can't be interpolated from the normalized c-Jun values, the smaller 
slope indicates that the rate of c-Jun decay is markedly slower in these cells.   
 
Stable reintroduction of STRAP rescues the c-Jun instability defect in STRAP 
knockout fibroblasts 
 
 To confirm that STRAP regulates c-Jun expression, STRAP null MEFs were 
transduced with retrovirus harboring empty vector or STRAP-HA and the effect of 
STRAP overexpression on c-Jun protein levels was examined by western blot (Figure 
14B, left).  Relative to the wild type, STRAP knockout and vector control fibroblasts 
exhibited a statistically significant reduction in c-Jun protein levels (Figure 14B, right).  
Ectopic expression of STRAP-HA increased c-Jun protein levels although endogenous 
STRAP expression levels were markedly higher in wild type MEFs.  These data suggest 
that STRAP can rescue the c-Jun instability defect in the knockout cell line.     
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Figure 14.  STRAP prolongs the half-life of c-Jun and increases c-Jun 
expression in STRAP knockout fibroblasts.   A.  Wild type and STRAP null 
fibroblasts were treated with cycloheximide (CHX) and lysed after 0, 0.5, 1, 2, 
and 4 hours of treatment.  c-Jun protein levels were analyzed by immunoblot 
analysis.   The c-Jun density was normalized against actin and the mean 
relative density of three independent experiments is shown (left).  To show c-
Jun decay over time, the relative densities (c-Jun density/Actin density) were 
normalized to the baseline c-Jun values for each culture.  The adjusted c-Jun 
values are plotted + SEM for three experiments (right).  B.  STRAP null 
fibroblasts were transduced with retrovirus to obtain polyclonal cultures 
expressing either an empty vector or a STRAP-HA construct.  The effects of 
enforced STRAP expression on c-Jun protein levels were determined by 
immunoblot analysis (left).  The c-Jun density was normalized against actin and 
the mean relative density from four independent experiments is shown.  
Statistical significance was determined using the Mann Whitney test (right).   
 
Reprinted from Biochem Biophys Res Comm (2011) 407, 372-7 with permission from Elsevier 
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STRAP promotes proliferation of MEFs 
 A role for STRAP as an oncogene has been proposed due to its ability to 
antagonize TGF-β mediated growth inhibition (Halder et al., 2006).  However, STRAP 
over-expression has been correlated with tumorigenicity in the absence of exogenous 
TGF-β (Halder et al., 2006).  In cell counting assays, STRAP knockout MEFs exhibited a  
marked defect in proliferation relative to the wild type cultures (Figure 15A).  The STRAP 
knockout MEFs also exhibited a significant decrease in thymidine incorporation, 
suggesting that STRAP promotes cellular proliferation (Figure 15B).  Because 
decreased cell numbers can be attributed to increased cell death, markers for apoptosis 
were examined by western blot analysis (Figure 15C).  As a positive control, wild-type 
MEFs were treated with 10 mM sodium butyrate for 24 hours to induce apoptosis.  
Minimal cleaved caspase-3 and PARP were detected in the untreated cultures, whereas 
both markers were present in the positive control.  Furthermore, visual examination of 
the cultures under normal growth conditions did not reveal any morphological changes 
associated with cell death or reduced viability (unpublished results).  Collectively, our 
observations suggest that STRAP promotes cellular proliferation in the absence of 
exogenous TGF-β.   
 
Discussion  
 
 Here, we show that STRAP regulates c-Jun expression by inhibiting the 
ubiquitylation and degradation of c-Jun.  It has been previously reported that STRAP 
decreases ubiquitylation of the p53 tumor suppressor through formation of a ternary 
complex with NM23 and p53 (Jung et al., 2007).  As expected, wild type fibroblasts 
expressed significantly more p53 than STRAP null fibroblasts.  However, unlike p53,  
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Figure 15.  STRAP expression promotes cellular proliferation.  A.  
Proliferation of wild type and STRAP knockout MEF cell lines was examined by 
counting cells over a five-day consecutive time course.  The data are presented 
as the log of the average cell number from six independent experiments.  The 
statistical significance between was determined using a mixed model ANOVA 
(p<0.001).  B.  Growth of wild type and STRAP knockout MEFs was assessed 
by measuring 3H-thymidine incorporation 46 hours after cell culture seeding.  
The data is presented as the log of the counts per minute (CPM) for six 
independent experiments.  Statistical analysis was performed using a mixed-
model ANOVA (p<0.001).  C.  MEF lysates were analyzed for markers of 
apoptosis by western blotting with antibodies directed against cleaved caspase-
3 and PARP.  Wild-type MEFs were pre-treated with sodium butyrate for 24 
hours as a positive control for apoptosis.  The relative density of caspase-3 and 
PARP was determined by normalizing against the corresponding actin band.  
The mean relative density from three independent experiments is shown.   
Reprinted from Biochem Biophys Res Comm (2011) 407, 372-7 with permission from Elsevier 
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c-Jun does not co-immunoprecipitate with STRAP (unpublished results).  This suggests 
that STRAP-mediated c-Jun stabilization occurs through a novel mechanism.  Previous 
studies have shown that c-Jun is a substrate for the ubiquitin E3 ligase, FBW7 (Wei et 
al., 2005).  FBW7-mediated degradation depends on GSK3β phosphorylation of T242 in 
the C-terminus of c-Jun.  Because treatment with the GSK3β inhibitor, LiCl, did not alter 
the basal level of c-Jun protein in MEFS, we do not expect c-Jun stability to be regulated 
by FBW7 in these cells.  In addition to FBW7, the ubiquitin E3 ligases Itch and 
DET/COP1 have been shown to promote c-Jun degradation.  Further work will be 
required to determine whether STRAP can influence c-Jun association with these E3 
ligases.   
 Previous studies have shown that c-Jun protein levels are up-regulated in 
squamous cell lung cancer (Woodrich and Volm, 1993) and transitional cell bladder 
carcinoma (Skopelitou et al., 1997) while STRAP protein overexpression has been 
detected in lung, colon, and breast cancers (Matsuda et al., 2000, Halder et al., 2006).   
 Interestingly, no gain-of-function mutations in c-Jun or STRAP have been described in 
human cancers.  However, loss of function mutations in the FBW7 c-Jun E3 ligase have 
been reported in leukemias (O'Neil et al., 2007;Song et al., 2008), suggesting that 
increased stabilization of FBW7 targets promote tumorigenesis.  Although FBW7 does 
not promote c-Jun turnover in fibroblasts, it is possible that STRAP-mediated 
stabilization of c-Jun contributes to cancer development.   
 While very little is presently known about the cellular functions of STRAP, it 
appears that STRAP can regulate a wide array of signaling pathways by associating with 
a diverse group of cellular proteins.  Although the specific biological function of STRAP 
varies according to its binding partner, STRAP binding to these proteins generally 
promotes signaling pathways and processes that are frequently associated with 
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tumorigenesis.  Previous studies on c-Jun indicate that its expression is important for 
cellular proliferation as c-Jun knockout MEFs exhibit a significant delay in cell cycle 
progression (Smith et al., 1992; Johnson et al., 1993).  Similarly, loss of STRAP 
significantly impairs the proliferation of MEFs suggesting that the defect in cellular 
growth may be in part due to increased turnover of c-Jun.   
  In light of the evidence that c-Jun signaling promotes tumor formation (Jin et al., 
2011; Sancho et al., 2009), STRAP over-expression could support cell autonomous 
tumor growth through deregulation of c-Jun expression.  My observation that STRAP 
that loss of STRAP decreases proliferation of fibroblasts raises the possibility that 
STRAP induction of AP-1 signaling could promote sarcoma growth.  Because the 
majority of cancers originate from dysplastic epithelia, it will be important to examine the 
effects of STRAP on c-Jun stability and growth in various epithelial cancer cell lines.  
Our preliminary data suggests that knockdown of STRAP in the lung adenocarcinoma 
cell line, A549, has a modest effect on proliferation whereas STRAP knockdown in the 
HeLa cervical cancer cell line does not inhibit growth (data not shown).  These findings 
highlight the contextual significance of changes in gene expression so it may be 
necessary to screen cell lines derived from a wide array of cancers to identify specific 
cancers where STRAP expression may have a significant biological effect.   
 In normal tissues, interactions between epithelial and stromal cells are not only 
important for maintenance of tissue architecture but also for regulation of normal 
biological processes including differentiation and growth.  Activation of signaling 
pathways leading to biological changes within the epithelium are partially due to stromal 
fibroblast secretion of soluble factors such as growth factors and chemokines.  It has 
been reported that cancer associated fibroblasts (CAFs) support tumorigenesis by 
modulating growth (Olumi et al., 1999; Cheng et al., 2005) and vascularization (Crawford 
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et al., 2009;Zhang et al., 2011).  CAFs isolated from human tumor tissues exhibit 
increased loss of heterozygosity at genetic hotspots (Weber et al., 2006; Weber et al., 
2007), suggesting that deregulated gene expression in stroma can have a significant 
effect on surrounding epithelial cells.  With respect to c-Jun, it has reported that loss of 
c-Jun expression in fibroblasts inhibits proliferation and terminal differentiation of 
keratinocytes in organotypic co-cultures (Maas-Szabowski et al., 2001).  Treatment with 
the AP-1 induced growth factors, GM-CSF and KGF, rescued the keratinocyte growth 
and differentiation defects (Maas-Szabowski et al., 2001), suggesting that stromal AP-1 
activity plays a critical role in the regulation of epithelial cell behavior.  Given that c-Jun 
ablation in stromal cells disrupts normal biological processes, the relative expression of 
c-Jun expression in fibroblasts may also affect growth of tumor cells.  Li et al. have 
reported that wild type fibroblasts exhibit a greater capacity for stimulation of benign 
prostatic hyperplasia (BPH) proliferation through IGF-1 paracrine signaling compared to 
c-Jun null fibroblasts (Li et al., 2007).  Collectively, these studies suggest that STRAP 
mediated stabilization of c-Jun in stromal cells could activate oncogenic signaling 
pathways in nearby epithelia through AP-1 dependent secretion of growth factors and 
cytokines.  Our microarray analysis indicates a 35-fold increase in GM-CSF expression 
in wild type fibroblasts relative to STRAP null MEFs (data not shown).  This may suggest 
that STRAP-mediated stabilization of c-Jun in the stroma can promote growth of 
associated epithelium through GM-CSF secretion.  However, further work will be 
required to establish a role for STRAP in epithelial-stromal interactions.   
 Based upon our findings and the literature published thus far, STRAP may 
promote cell growth and tumorigenicity by regulating the TGF-β, ERK, and c-Jun 
signaling pathways (Figure 16).   
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Figure 16.  STRAP regulation of cell growth pathways promotes cell autonomous 
and paracrine-stimulated growth.  STRAP regulates multiple cell signaling pathways 
that affect growth and tumorigenesis.  Canonical TGF-β signaling inhibits cellular 
proliferation through SMAD-dependent transactivation of anti-proliferative genes and 
repression of growth-inducing genes.  STRAP inhibits the anti-proliferative effects of 
TGF-β by sterically blocking TGF-β receptor association with SMAD-2 and -3, thereby 
blocking SMAD activation.  STRAP over-expression induces ERK activation, which can 
promote cell growth through activation of the transcription factors, ELK-1 and STAT3.  
Growth factor binding with cognate receptor tyrosine kinases (RTKs) promotes cellular 
proliferation through activation of MAP kinase pathways, including the JNK/c-Jun axis.  
Phosphorylated c-Jun and its binding partner, c-Fos, form the AP-1 transcription factor, 
which promotes cell cycle progression by inducing transcription of genes necessary for 
the G1/S transition.  STRAP mediated inhibition of c-Jun turnover increases the total 
cellular pool of c-Jun, thereby permitting increased activation and transcription of AP-1 
targets.  Increased AP-1 activity also leads to the production and secretion of soluble 
factors that can promote the growth of nearby cells through paracrine signaling.   
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Chapter III 
 
STRAP PROMOTES PERSISTENT MIGRATION AND TAIL RETRACTION 
DURING CHEMOTAXIS 
 
Introduction 
 Loss of STRAP expression in the developing mouse causes gross morphological 
defects in somitogenesis, organogenesis, and neural tube closure (Chen et al., 2004).  
Interestingly, many of the observed defects have been associated with a failure in 
embryonic EMT (Zohn et al., 2006; Zwerts et al., 2007).  It has recently been reported 
that immortalized embryonic fibroblasts isolated from the STRAP knockout mouse 
express E-cadherin and exhibit an epithelioid morphology (Figure 17A) (Kashikar et al., 
2010).  During the early stages of embryonic patterning, epithelial cells undergo an EMT, 
which is characterized by the down-regulation of epithelial markers, such as E-cadherin, 
and induction of mesenchymal genes (Duband et al., 1995; Boyer and Thiery, 1998).  
Embryonic EMT, referred to as Type 1 EMT involves primitive epithelial cells that 
undergo mesenchymal transdifferentiation and populate different organ systems (Kalluri 
and Weinberg, 2009).  These cells can then revert to an epithelial cell type, through a 
process called mesenchymal-to-epithelial transition (MET), and support organ 
development in their resident tissue.   
 Given that STRAP knockout mice have defects in organogenesis and STRAP 
null fibroblasts do not exhibit normal fibroblastoid morphology, it is possible that loss of 
STRAP impairs type 1 EMT.  Analysis of various epithelial and mesenchymal markers 
indicated that STRAP knockout MEFs express markers of both lineages (summarized in 
Table 3) (Kashikar et al., 2010).  Furthermore, enforced expression of STRAP in the 
STRAP null MEFs was sufficient to abrogate E-cadherin expression, upregulate 
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fibronectin (Figure 17B), and induce a morphological switch to a fibroblast-like 
phenotype (Kashikar et al., 2010).  Collectively, these findings may suggest that loss of 
STRAP does not inhibit all of the molecular changes associated with EMT but is 
sufficient to inhibit acquisition of a spindle-shaped morphology.   
   
 
 
 
  
Figure 17.  STRAP suppresses E-cadherin expression in MEFs.  A.  Loss of STRAP 
expression in MEFs results in an epithelioid morphology coincident with up-regulation of 
E-cadherin.   B. Stable reintroduction of STRAP into the STRAP null MEFs decreases 
expression of the epithelial marker, E-cadherin, and increases expression of the 
fibroblast marker, fibronectin.   
Reprinted from Cell Signal (2010) 22, 138-49 with permission from Elsevier 
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  Western Blot   RT-PCR 
EMT markers WT KO    WT  KO  
Acquired           
N-cadherin ⁺ ⁺⁺   ND ND 
FSP1 ND ND   ⁺ ⁺ 
Vimentin ⁺ ⁺⁺   ND ND 
β-catenin ⁺ ⁺⁺   ND ND 
Fibronectin ⁺⁺ ⁻   ND ND 
Snail ND ND   ⁺ ⁺ 
Slug ND ND   ⁺ ⁺ 
Twist ND ND   ⁺ ⁺ 
LEF1 ND ND   ⁺ ⁻ 
Attenuated           
E-cadherin ⁻ ⁺⁺⁺   ⁻ ⁺⁺⁺ 
ND-not determined 
     Summarized from Cell Signal 22 (2010) 138-49. 
 
 
 
 
 Although EMTs in the embryo and adult organisms may differ in the expression 
of markers, a common feature of EMT is an increased capacity for cellular motility (Bakin 
et al., 2000; Bakin et al., 2002; Xu et al., 2003).  Embryonic EMT is required for proper 
developmental patterning whereas EMT in the adult regulates wound healing processes 
(Savagner et al., 2005; Hudson et al., 2009).  EMT also plays an important role in the 
dissemination of cancer cells from the primary tumor (Smit and Peeper, 2011; Wendt et 
al., 2011).  While these preliminary studies highlight the importance of STRAP in 
embryonic development and cell fate determination, the relationship between 
morphology and motility was not examined.   
Table 3.  Epithelial and mesenchymal markers expressed by wild type and 
STRAP null MEFs 
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 The aim of this project is to explore the role of STRAP in migration.  Based on 
the morphological differences associated with STRAP expression, we hypothesized that 
STRAP may promote cellular motility by regulating the expression or activation of 
proteins involved in actin cytoskeleton remodeling.  In the event that STRAP promotes 
cellular migration, targeted inhibition of STRAP may be a useful avenue for the treatment 
of metastatic cancers.   
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Materials and methods 
 
Cell culture and plasmids 
Immortalized wild type and STRAP knockout Mouse Embryonic Fibroblasts (MEFs) were 
a gift from Dr. Philippe Soriano (Mount Sinai Medical Center, New York, NY).  MEF and 
HT29 colon adenocarcinoma cultures were maintained in DMEM medium supplemented 
with 7% FBS.  The STRAP shRNA and GIPZ empty vector control were purchased from 
Open Biosystems (Huntsville, AL).  The viral packaging plasmids pMD2.G and psPAX2 
are available from Addgene (Cambridge, MA; deposited by Didier Trono).  The Akt-PH-
eGFP expression construct was generously provided by Dr. Ann Richmond.   
 
Reagents and antibodies 
Lipofectamine LTX, Phalloidin-Alexa Fluor 594, Alexa-Fluor conjugated secondary 
antibodies, and Prolong Gold mounting medium were purchased from Invitrogen 
(Carlsbad, CA).  Mitomycin C, Fibronectin, nocodazole, phosphatase inhibitor cocktails, 
and protease inhibitor cocktails were purchased from Sigma (St. Louis, MO).  Type I 
collagen was obtained from BD Biosciences (Sparks, MD).  The pFAK and FAK 
antibodies are from Cell Signaling (Danvers, MA).  The β-tubulin antibody was obtained 
from the University of Iowa Developmental Biology Hybridoma Bank (Iowa City, Iowa) 
and the STRAP monoclonal antibody was purchased from BD Transduction Labs (San 
Jose, CA).   
 
Generation of stable cell lines 
Lentivirus for STRAP knockdown was generated by co-transfecting 293T cultures with 
the shRNA GIPZ vector (Open Biosystems clone ID V2LMM_14787) and the plasmids 
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encoding viral proteins, psPAX2 and pMD2.G.  Two days post-transfection, the viral 
supernatant was centrifuged at 1000 rpm and passed through a 0.45 µm syringe filter.  
The clarified viral supernatant was then applied directly to wild-type MEF and HT29 
cultures.  The following morning, the viral supernatant was aspirated off the cells and the 
cultures were fed with DMEM containing 7% FBS.  Twenty four hours later, the MEFs 
and HT29 cells were selected with 1 µg/ml of puromycin.  After puromycin selection, 
single colonies were isolated from the polyclonal population of MEFs and screened for 
STRAP expression by immunoblot analysis using a mouse monoclonal STRAP antibody.  
Monoclonal cell lines were not derived for the HT29 cultures.  The procedure for 
generation of the STRAP-HA and vector control cells has been described in the previous 
chapter.   
 
Immunofluorescence 
MEFS were seeded in chamber slides coated with 10 µg/ml fibronectin.  The attached 
cells were fixed with 4% paraformaldehyde for 10 minutes and permeabilized with 1% 
Triton X-100 for 8 minutes.  The fixed cells were blocked with 10% BSA for 30 minutes 
and incubated with rabbit anti-pFAK Y397 overnight.  pFAK 397 was detected by 
staining with a anti-rabbit secondary conjugated to Alexa Fluor 594.  Coverslips were 
mounted with Prolong Gold containing DAPI.  
 
Transwell migration assay 
The underside of Corning/Costar 8.0 µm, 6.5 mm transwell inserts (Lowel, MA) were 
coated with 100 µg/ml of collagen I overnight at 4:C.  The following morning, the inserts 
were washed 2-3 times with serum free medium to neutralize the pH of the collagen 
coating.  The upper surface of the insert was then blocked with 10% sterile-filtered BSA 
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for one hour at 37:C.  The BSA was aspirated and 4 x 104 MEFs or 2 x 104 HT29 cells, 
suspended in serum free media, were seeded in triplicate into the upper chamber of 
transwell inserts.  Cells were allowed to migrate towards a gradient of 7% FBS for 5 
hours before fixation with 4% paraformaldehyde.  After 30 minutes of fixation, the 
paraformaldehyde was aspirated and the cells were stained with 1% crystal violet at 
least one hour.  The crystal violet was aspirated and the inserts were washed with 
copious amounts of water.  The water was aspirated out of the well and 1 ml of 1X PBS 
was pipetted into each well.  A moistened cotton swab was used to remove cells and 
debris from the upper surface of the transwell inserts.  Cells in five randomly selected 
fields were counted for each triplicate well.  For each experiment, the average number of 
cells per culture was determined by averaging the number of cells counted per field in 
each replicate.  The data presented represents the average number of cells from at least 
three independent experiments + SEM.  For comparison of the wild type and STRAP 
knockout MEFs, statistical significance was determined using the Wilcoxon signed rank 
test.  Statistically significant differences in the motility of STRAP knockdown MEFs and 
HT29 cultures were determined using ANOVA.   
 
Wound closure assay 
Wild type and STRAP knockout MEFs were grown to confluence in 6 well plates.  Prior 
to wounding, the cultures were pre-treated with 0.5 µg/ml mitomycin C for 3 hours.  A 
single scratch was introduced into the cell monolayer with a 100 µl pipet tip and the 
dislodged cells were removed by washing the cultures in DMEM.  The cultures were 
refed with DMEM containing 0.5 µg/ml mitomycin C and cell migration into the wound 
was monitored up to 24 hours post-wounding.  
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Live cell imaging 
Wild type and STRAP knockout MEFs were seeded into petri dishes coated with 10 
µg/ml of fibronectin and allowed to attach overnight.  The following morning, the cultures 
were serum starved for seven hours.  A gradient of FBS was delivered to the cells using 
a 0.8 μm transwell insert secured to the top of the petri dish lid.  Chemotaxis was 
monitored for 5 hours by time lapse video microscropy.  The migration of individual cells 
was tracked using Molecular Device's Metamorph software.  A representative cell track 
is shown with the red dot representing the final recorded position of the tracked cell.  The 
data from at least three independent experiments was pooled for analysis of the distance 
to origin (distance of the final recorded position from the first point in the track) and mean 
velocity.  The distance to origin is displayed at the mean value + SEM.  The average 
velocity for each tracked cell is shown on a scatter plot along with the mean velocity + 
SEM for the each population.  Statistical significance was determined using the Mann 
Whitney test (p<0.0001).   
 
Uropod formation and retraction  
Images of cell tails were recorded by time lapse video microscopy as previously 
described.  For determination of tail formation, the number of cells containing 
discernable tails was manually counted from images taken before chemotaxis.  The 
percentage of cells within the field of view was calculated for three independent 
experiments and plotted as the average percentage + SEM.   Statistical significance was 
determined using a paired t-test.  The length of the tails was quantified using the 
Metamorph region measurement tool.  The tail length measurements from three 
independent experiments were pooled for each group.  The data is presented as the 
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mean tail length + SEM.  Statistical significance was determined using an unpaired t-
test.   
 
Akt localization assay 
Approximately 2.5 x 105 wild type and STRAP null MEFs were seeded into 6 cm petri 
dishes and cultured overnight in DMEM containing 10% FBS.  The following day, the 
cultures were transfected with 1 µg of an Akt-PH-eGFP expression construct using 
Lipofectamine LTX reagent.  The DNA-lipofectamine complexes were aspirated 4 hours 
after transfection and the cultures were fed with DMEM containing 10% FBS.  The 
following morning, wild type and STRAP null MEFs were seeded at low density into 35 
mm glass-bottom dishes coated with 10 µg/ml fibronectin.  Twenty four hours later, the 
cultures were serum starved for 5-7 hours.  A gradient of FBS was generated as 
previously described and GFP recruitment to the plasma membrane was recorded by 
time lapse video microscopy.  Bright-field and GFP images were taken every minute for 
30 minutes.   
 
Adhesion assay 
96-well plates were coated overnight at 4:C with 10 µg/ml type I collagen or 5 µg/ml 
fibronectin.  The wells were washed three times with 0.1% BSA and blocked with 0.5% 
BSA for one hour at 37:C.  The wells were washed again with 0.1% BSA and 3x 104 
MEFs were seeded into triplicate wells.  The cells were allowed to attach to the matrix 
for one hour before washing cultures 3 times with 0.1% BSA.  The attached cells were 
then fixed with 4% paraformaldehyde for 10 minutes at room temperature and stained 
with 0.5% crystal violet for 10 minutes.  The plates were washed with copious amounts 
and water and allowed to dry before solubilization of crystal violet with 1% SDS for 30 
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minutes.   The absorbance550 was measured in the Molecular Device's SpectroMax M5 
plate reader and the average of the triplicate measurements was calculated.  The data is 
presented as the mean absorbance of four independent experiments + SEM.   
 
Cell spreading assay 
Chamber slides were coated overnight at 4:C with 10 µg/ml fibronectin.  5 x 103 MEFs 
were seeded/well and allowed to attach for one hour.  The cultures were then fixed with 
4% paraformaldehyde for 10 minutes and permeabilized with 0.1% Triton X-100 for 10 
minutes.  The fixed cultures were blocked for one hour with 10% BSA and stained with 
phalloidin-Alexa Fluor 594 diluted 1:50 in 10% BSA for one hour.  The wells were 
washed three times with PBS and coverslips were mounted with Prolong Gold 
containing DAPI.  Random fields were selected for image acquisition and the total cell 
size/area was measured for each group (n< 40) with Metamorph's integrated 
morphometry analysis software.  The area of each cell is displayed on a scatter plot 
along with the mean area + SEM.  Statistical significance was determined using the 
Student's t-test.  The results are representative of at least three independent 
experiments.   
 
Focal adhesion disassembly assay 
Chamber slides were coated overnight at 4:C with 10 µg/ml fibronectin.  Approximately 5 
x 103 wild type and STRAP null MEFs were seeded/well and allowed to attach overnight.  
The cultures were then treated with 10 µM nocodazole for 6 hours to dissociate 
microtubules.  The nocodazole containing medium was aspirated and replaced with 
DMEM containing 10% FBS.  The cultures were fixed with 4% paraformaldehyde at 0, 
0.5, 1, and 2 hours after nocodazole washout and permeabilized with 0.1% Triton X-100.  
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After blocking with 10% BSA for 30 minutes, the cells were incubated with rabbit 
phospho-FAK Y397 (1:250) and mouse β-tubulin (1:250) antibodies overnight at 4:C.   
Secondary anti-rabbit-Alexa Fluor 488 and anti-mouse-Alexa Fluor 594 were used for 
detection of p-FAK and β-tubulin by immunofluorescent microscopy.   
 
Western blot 
Cells were lysed in RIPA buffer containing 10 mM Tris [pH 7.2], 150 mM NaCl, 5 mM 
EDTA, 0.1% SDS, 1% Triton X-100, and 1% sodium deoxycholic acid supplemented 
with Sigma protease inhibitor and phosphatase inhibitor cocktails (1:100).  The cells 
were scraped and the lysates were incubated on ice for 20 minutes before centrifugation 
at 13,000 rpm for 15 minutes at 4°C.  The protein concentration of the clarified lysates 
was then measured using Bradford reagent.  Equal concentrations of protein extracts 
were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to 
polyvinylidene fluoride (PVDF) membranes (Bio-Rad, Hercules, CA).  The membranes 
were then immunoblotted with the indicated antibodies.  
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Results 
 
STRAP is a positive regulator of cell migration 
 We have recently reported that STRAP expression in MEFs is required for the 
acquisition of a mesenchymal morphology in mouse embryonic fibroblasts.  Because a 
fibroblastoid morphology is associated with an increased capacity for migration, we 
directly tested the motility of wild type and STRAP null fibroblasts in Boyden chamber 
assays using serum as a chemoattractant.  As expected, a significantly greater number 
of wild type MEFs migrated to the other side of the transwell insert than the epithelial-like  
STRAP knockout MEFs (paired t-test, p<0.005) (Figure 18A).  To further examine the 
effects of STRAP expression on cell migration, STRAP was knocked down in wild-type 
MEFs and the colon adenocarcinoma cell line, HT29, by lentiviral transduction of 
shRNA.  Individual clones (designed C, F, and J) were isolated from polyclonal mouse 
fibroblast cultures after selection and STRAP knockdown was confirmed by western blot 
analysis (Figure 18B).  The motility of the monoclonal cultures was then tested in 
Boyden  chamber assays.  As shown in Figure 18B, STRAP knockdown MEFs exhibited 
a statistically significant reduction in migration towards serum compared to wild type 
fibroblasts (ANOVA, p<0.005).  A Dunnett's multiple comparison post-test confirmed that 
the motility of wild type MEFs was significantly greater than the STRAP knockout and  
STRAP knockdown fibroblasts.   STRAP knockdown polyclonal HT29 cultures 
(designated 87-1 and 87-2) also exhibited a marked reduction in cell motility relative to 
the parental and vector control culture (Figure 18C).  Collectively, these findings suggest 
that STRAP expression promotes directed motility.   
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Figure 18.  STRAP expression promotes cell migration.  A.  Boyden chamber assays 
were performed to assess the motility of wild type and STRAP knockout fibroblasts 
towards a gradient of 7% serum.  The average number of cells/field + SEM from ten 
independent experiments is shown.  Statistical significance was determined using a 
paired t-test (p<0.005).  B,C.  The effects of STRAP knockdown on the motility of 
monoclonal MEF (B) and polyclonal HT29 cultures (C) was examined using Boyden 
chambers.  Seven percent FBS was used as a chemoattractant.  The average number of 
cells/field + SEM from at least three independent experiments is shown.  Statistically 
significant differences in the migration of STRAP knockdown MEF and HT29 cultures was 
determined using one-way ANOVA (MEF shRNA experiment, p<0.005).  A Dunnett's 
multiple comparison post-test confirmed that there were significant differences in 
migration between the wild type MEFs and the other fibroblast cultures.   
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Loss of STRAP increases cell adhesion and spreading 
 Because motility defects are often associated with increased cell adhesion, the 
effects of STRAP on cell-matrix attachment and cell spreading was investigated.  Wild 
type and STRAP knockout fibroblasts were seeded onto fibronectin and collagen 
matrices and permitted to attach for one hour.  Loss of STRAP markedly increased 
adhesion to fibronectin (Figure 19A).  Similarly, loss of STRAP increased cell attachment 
to type I collagen (Figure 19B).  Cell spreading was examined by seeding wild type and 
STRAP knockout MEFs on fibronectin for one hour followed by phalloidin staining to 
demarcate the cell boundaries.  In accordance with the increased adhesiveness, STRAP 
knockout MEFs generally appeared to spread more on fibronectin than wild-type 
fibroblasts (Figure 19C), suggesting that loss of STRAP promotes cell spreading.  
Metamorph software was then used to quantify cell spreading as a function of cell size.  
Based on the analysis of randomly selected cells, loss of STRAP expression significantly 
enhanced spreading on fibronectin (unpaired t-test, p<0.001) (Fig. 19D).  Taken 
together, these findings may suggest that STRAP promotes motility by limiting the 
relative strength of cell-matrix adhesions.   
 FAK incorporation and subsequent activation in immature focal contacts 
promotes cell adhesion and spreading through activation of various effector proteins.  
Because loss of STRAP increased fibroblast adhesion and spreading, STRAP may be 
involved in the recruitment of FAK to protrusive membrane structures.  To examine the 
effects of STRAP on the subcellular distribution of activated FAK, wild type and STRAP 
null MEFs were seeded onto fibronectin and allowed to spread for four hours before 
immunostaining for phospho-FAK Y397 (Figure 19E).  Wild-type fibroblasts exhibited 
large peripheral phospho-FAK foci that were predominantly concentrated at protrusive 
regions.  Conversely, STRAP null fibroblasts had small punctate peripheral pFAK foci 
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Figure 19.  Loss of STRAP promotes cell adhesion and spreading.   A,B.  Wild 
type and STRAP knockout MEFs were seeded into 96 wells plates coated with 5 
μg/ml fibronectin (A) and 10 µg/ml collagen (B).  The cells were allowed to attach for 
one hour before fixation and crystal violet staining.  The relative adhesion + SEM 
from four independent experiments is plotted as a function of absorbance550.  C.  
Wild type and STRAP null fibroblasts were seeded into chamber slides coated with 
10 μg/ml fibronectin.  The cells were allowed to attach and spread for one hour 
before staining with phalloidin-Alexa Fluor 594.  Images were acquired using a 63X 
objective.  D.  Cell spreading was quantified by using Metamorph software to 
measure the total area of randomly selected cells (N>40).  The plot represents the 
average area + SEM.   Statistical significance was determined using an unpaired t-
test (p<0.001).  The experiment was repeated at least three times with similar 
results.  E. The relative distribution of focal adhesions was examined by 
immunostaining wild type and STRAP null MEFs for activated FAK.  MEFs were 
seeded on fibronectin plates and incubated with a phospho-specific antibody directed 
against Y397 four hours post-seeding.  Images were taken using a 63X objective. 
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with numerous large foci that were distributed along the basal surface of the membrane.   
These findings may suggest that loss of STRAP promotes adhesion through stabilization 
of centrally-located focal adhesions.   
 
STRAP regulates persistent chemotactic migration  
 In order to investigate the importance of cell-matrix adhesions with respect to the 
mechanics of motility, the motility of single cells was observed by time lapse video 
microscopy.  Serum-starved wild type and STRAP null MEFs were exposed to a gradient 
of fetal bovine serum and cell migration was recorded for 5 hours.  Metamorph software 
was then used to track the trajectory of individual cells during the elapsed time.  As 
shown by the cell tracks (Figure 20A), wild type MEFs generally maintained an 
orientation and migratory path towards the gradient source whereas the STRAP null 
fibroblasts failed to initiate and/or maintain migration in the direction of the gradient.  This 
suggests that STRAP is necessary for persistent migration.  Although STRAP appears to 
be required for persistence during chemotactic migration, loss of STRAP surprisingly 
increased the rate of single cell migration (Figure 20B).  Furthermore, the distance 
between the cell's point of origin and final destination was significantly higher in STRAP 
null fibroblasts, despite the tendency to change course (Figure 20C).   Given that loss of 
STRAP expression disrupts directed migration in live cell chemotaxis and Boyden 
chamber assays, the effects of STRAP on the motility of mitomycin C-treated wild type 
and STRAP null fibroblasts was examined in a wound closure assay (Figure 20D).  
STRAP knockout fibroblasts were able to efficiently close wounds at comparable or 
faster rates than wild-type MEFs.  This finding suggests that loss of STRAP does not  
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Figure 20.  STRAP is required for persistent chemotaxis.  A.  Chemotaxis of 
wild type and STRAP knockout MEFs towards a serum gradient was examined by 
time-lapse video microscopy.  Cell motility was recorded for 5 hours and the 
trajectory of individual cells within the field was tracked using Metamorph software.  
The final position of each cell is shown as a red circle.  The asterik (*) indicates the 
direction of the gradient source.  B.  The velocity of wild type and STRAP null 
MEFs from at least three independent experiments are shown.  The average 
velocity (µm/minute) of individual wild type and STRAP null MEFs was plotted with 
the mean velocity + SEM shown for each group.  Statistical significance was 
determined using the Mann Whitney test (p<0.0001).  C.  The mean distance from 
the origin + SEM is shown.  Statistical significance was determined using the 
Mann Whitney test (p<0.0001)  D.  The motility of wild type and STRAP 
knockdown MEFs was examined by wound healing assays.  Migration into the 
wound was documented at 0 and 22 hours post-wounding.   
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diminish the capacity for migration but inhibits the ability to persistently migrate towards 
a chemical gradient.   
  The mechanisms that regulate gradient sensing and persistent migration are 
poorly understood.  It has been reported that phosphoinositide-3-phosphate (PI3K) 
mediated recruitment of AKT to the plasma membrane is an essential step in chemotaxis 
(Yoo et al., 2010).  Since STRAP knockout disrupts fibroblast chemotaxis, the effects of 
STRAP on the AKT membrane recruitment was investigated using a fusion protein 
comprised of the pleckstrin homology (PH) domain of AKT fused to enhanced green 
fluorescent protein (AKT-PH-eGFP).  The pleckstrin homology domain targets AKT to 
the plasma membrane through direct association with the membrane phospholipid, PIP3.  
As such, exposure to a gradient of chemoattractant would result in a cycle of AKT 
membrane recruitment followed by diffusion.   Changes in AKT-PH-eGFP localization in 
wild type and STRAP null MEFs was monitored by time-lapse video microscopy after 
exposure to a gradient of serum (Figure 21).  GFP was recruited to membrane ruffles 
and protrusions in both cell lines, suggesting that the persistent motility of wild type 
MEFs can not be attributed to enhanced AKT recruitment to the leading edge.   
 
Loss of STRAP is associated with decreased tail retraction and altered  
phospho-FAK Y397 distribution 
 We have shown that loss of STRAP is correlated with increased cell adhesion to 
ECM proteins and large centrally-located focal adhesions, but these attachments do not 
inhibit cell motility.  During cell migration, nascent cell attachments to the underlying 
matrix are formed beneath the leading edge and attachments at the rear of the cell must 
be disassembled to facilitate forward movement.  Time lapse video microscopy of 
migrating cells revealed defective uropod retraction in STRAP null MEFs.  Loss of 
STRAP expression resulted in long tails that often grew as the leading edge and cell  
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Figure 21.  Loss of STRAP does not inhibit AKT membrane recruitment.  Wild type 
and STRAP knockout fibroblasts were transiently transfected with AKT-PH-eGFP and 
seeded onto fibronectin.  Time lapse images of AKT recruitment were recorded for 30 
minutes after application of a gradient of serum.  The location of the gradient source is 
indicated with an asterik.  Arrows and bars indicate regions of AKT membrane 
recruitment.   
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 body moved forward whereas persistent tails were not observed on wild-type MEFs 
(Figure 22).   
 The defective tail retraction in STRAP null MEFs suggests that STRAP may 
regulate dissolution of cell-matrix adhesions.  To investigate the role of STRAP in focal 
adhesion turnover, focal adhesion disassembly assays were performed using wild type 
and STRAP null MEFs (Figure 23).  Treatment with 10 µM nocodazole effectively 
inhibited microtubule assembly and induced cell retraction in both wild type and STRAP 
null fibroblasts.  After nocodazole washout, wild type fibroblasts exhibited consistent 
peripheral FAK staining during cell spreading suggesting that microtubule-mediated 
disassembly of older focal adhesions occurs at a comparable rate as the assembly of 
new peripheral adhesions.  Conversely, STRAP null MEFs initially show increased  
Figure 22.  STRAP is required for efficient tail retraction during chemotaxis.   
Time-lapse images of cells undergoing chemotaxis were recorded for five hours.  The 
morphology of a single wild type and STRAP knockout fibroblast is shown at 0, 120, 
180, 240, and 300 minutes.  Cell tails are denoted with arrowheads. 
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Figure 23.  Loss of STRAP alters the distribution of phospho-FAK Y397.   
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peripheral FAK activation but foci containing active FAK appeared more punctate and  
 
centrally located as cell spreading progressed.  This suggests that nascent attachments  
 
are formed as the STRAP null MEFs spread but the older adhesions are not  
 
disassembled.   
 
  
 
Ectopic expression of STRAP rescues the defect in directed migration and 
attenuates tail formation  
 
 In order to determine whether the effects of STRAP expression on fibroblast 
motility and tail retraction are specific, HA-tagged STRAP or empty vector was stably 
reintroduced into STRAP null MEFs by retroviral transduction.  After positive selection 
with puromycin, individual clones were isolated from the polyclonal populations of  
 
 
 
 
  
Figure 24.  Reintroduction of STRAP into the STRAP null MEFs increases cell 
migration.  A.  Western blot analysis for STRAP expression in STRAP knockout MEF 
clones stably transduced with pBABE empty vector or pBABE-STRAP-HA.  The lower 
molecular weight band is the endogenous ("end.") form of STRAP while the higher 
molecular weight band is the epitope-tagged exogenous ("exo.") STRAP.  B.  The 
motility of the stable vector control and STRAP-HA clones was examined in a Boyden 
chamber assay.  Seven percent fetal bovine serum was used as a chemoattractant.   
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pBABE vector and pBABE-STRAP-HA cultures.  Expression of exogenous STRAP-HA 
was confirmed by western blot analysis (Figure 24A) and the motility of the monoclonal 
cell lines was then examined in Boyden chamber assays using serum as a 
chemoattractant (Figure 24B).  Ectopic expression of STRAP-HA in the null background 
markedly increased migration compared to the parental STRAP null fibroblasts and 
pBABE vector control, suggesting that STRAP is sufficient to rescue the persistent 
motility defect.   
 The effects of STRAP expression on tail retraction was then examined by time 
lapse video microscopy.  Vector control clone 7 and STRAP-HA clone 8 were seeded 
onto fibronectin and serum starved before application of a gradient of serum.  During 
chemotaxis, wild type cells generally exhibited a pattern of limited tail growth followed by 
retraction (Figure 25A).  Conversely, a markedly greater number of vector control cells 
showed considerable defects in tail retraction during motility.  The failure to retract 
singular tails was often accompanied by branching or formation of additional uropods 
(Figure 25A).  Interestingly, the vector control cultures showed increased tail formation 
prior to initiation of chemotaxis, possibly due to retraction defects during random 
migration on fibronectin (Figure 25B).  To quantitatively show differences in tail formation 
between vector control and STRAP-HA expressing cultures, the percentage of cells  
within the field of view that exhibited distinctive tails was calculated from three 
independent experiments.  Compared to the STRAP-HA cultures, the vector control 
cultures had a significantly higher percentage of cells with tails (Figure 25C).  The tail 
lengths were measured using Metamorph software and the individual values from three 
separate experiments were pooled for statistical analysis.  As shown in Figure 25D, 
vector control cells had significantly longer tails than the STRAP-HA expressing cells.   
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Figure 25.  Ectopic STRAP in STRAP null fibroblasts reduces tail growth.  A. Time-
lapse images of cells undergoing chemotaxis were recorded for five hours.  The 
morphology of a single cell from a STRAP knockout vector control clone 7 and STRAP-HA 
stable clone 8 is shown at 0, 120, 180 240, and 300 minutes.  Asteriks (*) indicate the 
location of the gradient source.  Cell tails are denoted with white arrowheads.  B.  Images 
of STRAP knockout vector control and STRAP-HA clones before (time=0) and after 
chemotaxis (time=5 hours).  20X images show increased presence of singular and 
branched tails in the vector control population.  C.  Tail formation prior to chemotaxis was 
quantified by determining the percentage of cells within a field that exhibited definitive 
uropods.  Data from three independent experiments are shown.  Statistical significance 
was determined with a paired t-test (p<.005).  D.  Tail lengths of vector control and 
STRAP-HA stable clones was measured using Metamorph software.  The average length 
of cells was calculated by pooling the tail measurements from three independent 
experiments.  Statistical significance was determined using an unpaired t-test (p<.05).    
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Collectively, these data may suggest that ectopic STRAP expression in the STRAP 
knockout fibroblasts suppresses tail growth during random and directed migration.   
 
STRAP regulates FAK subcellular localization 
 Our data suggests that loss of STRAP expression is correlated with larger 
centrally-located pFAK foci and defective tail retraction.  Because ectopic STRAP 
expression in STRAP null MEFs reduces tail formation, we predicted that exogenous 
STRAP may induce changes in pFAK localization.  To further examine the effects of 
STRAP expression on pFAK distribution, the stable pBABE-STRAP-HA expressing 
monoclones and corresponding control cultures were seeded onto fibronectin for four 
hours and immunostained for pFAK Y397.  In accordance with our previous findings, 
wild type MEFs exhibit strong peripheral FAK staining, concentrated at protrusive 
regions while the STRAP knockout MEFs contain numerous large internal pFAK foci 
(Figure 26).  Similar to the STRAP null MEFs, vector control cultures showed large 
internal pFAK puncta with small pFAK adhesions at the edges of membrane ruffles.   
Although the morphology of the STRAP stable clones was variable, STRAP expression 
appeared to increased peripheral pFAK localization and decrease central pFAK staining.  
These findings may suggest that STRAP affects tail growth by regulating the relative 
distribution of focal adhesion structures.   
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Figure 26.  STRAP regulates phospho-FAK localization.  Wild type, STRAP 
knockout, STRAP -/- pBABE vector control, and STRAP -/- pBABE-STRAP-HA 
expressing fibroblast cultures were seeded onto fibronectin.  Four hours after seeding, 
the cultures were immunostained for pFAK Y397 to show the distribution of focal 
adhesion complexes.  Ectopic overexpression of STRAP in the STRAP null MEFs was 
associated with a reduction in large, central adhesions and an increase in peripheral 
pFAK staining.       
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Discussion  
 
 Previous studies have shown that loss of STRAP expression prevents mouse 
embryonic fibroblasts from acquiring a mesenchymal morphology during development, 
possibly due to arrested embryonic EMT.  Given that EMTs are associated with a motile 
phenotype, we hypothesized that STRAP expression would promote cellular motility.  
Initial investigation of the relative motility of wild type and STRAP null fibroblasts 
supported this hypothesis.  Knockdown of STRAP in wild type MEFs and HT29 colon 
adenocarcinoma cells also decreases migration in Boyden chamber assays. However, it 
will be important to repeat these experiments using non-target shRNA controls and 
additional STRAP-specific shRNAs to address concerns regarding off-target effects of 
shRNA.   
  A defect in the basic mechanics of cell motility was initially presumed due to the 
reduced migration of STRAP null and STRAP knockout cell lines in Boyden chamber 
assays.  Surprisingly, live cell imaging experiments suggest that loss of STRAP 
expression adversely affects persistent migration towards a gradient of serum.  
Reintroduction of STRAP into the STRAP knockout MEFs rescued motility in Boyden 
chamber assays, suggesting that STRAP is required for directed migration towards a 
chemoattractant.  Interestingly, both wild type and STRAP knockout MEFs were able to 
effectively recruit Akt to the cell membrane, suggesting that upstream activation of 
GPCRs and PI3K occur in both cell types.  It has been reported that αvβ3 integrin 
expression promotes persistent migration of epithelial cells whereas α5β1 integrin 
promotes random migration by stimulating RhoA activity at the leading edge (Danen et 
al., 2005).  Likewise, inhibition of αvβ3 endocytic recycling has been reported to disrupt 
persistent migration of fibroblasts due to increased recycling of α5β1 integrin (White et 
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al., 2007).  In light of the increased adhesion exhibited by STRAP null MEFs, it is 
tempting to speculate that differences in the integrin expression profile could account for 
the differences in migrational persistence and adhesion.  However, increased α5β1 
activation is associated with reduced polarity (Danen et al., 2005; White et al., 2007) and 
the STRAP null MEFs appeared to be more polarized than wild type fibroblasts (data not 
shown).  It is plausible that loss of STRAP may cause random motility by activating 
RhoA downstream of cell polarization.   
 Our preliminary data also suggests that STRAP may have a role in the regulation 
of cell adhesion dynamics during cell spreading and migration.  Loss of STRAP 
expression in fibroblasts increased adhesion and cell spreading on extracellular matrix 
proteins and inhibited tail retraction during chemotaxis.  Because cell attachment to 
matrix is regulated by integrin receptors, it is possible that STRAP affects the expression 
or activation of cell surface integrin receptors.  The contribution of integrins to the 
adhesive properties of these cells can be explored by investigating the integrin 
expression profile of wild type and STRAP null MEFs by flow cytometric analysis.  
 Despite the defect in tail release while migrating on fibronectin, STRAP knockout 
MEFs appeared to efficiently form adhesions at the leading edge as their rate of 
migration was signficantly higher than wild type fibroblasts.  This may suggest that 
STRAP is differentially regulating adhesion structures at the front and rear of migrating 
cells.  Immunofluorescent staining for pFAK Y397 revealed significant differences in the 
distribution of focal adhesion structures between wild type and STRAP null MEFs.  In the 
absence of STRAP, fibroblasts exhibited punctate peripheral pFAK staining and larger 
foci distributed throughout the basal surface of the cell.  The smaller peripheral foci may 
represent immature focal complexes while the large central foci may be focal adhesions 
that have undergone maturation.  During directed migration, the majority of immature 
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focal complexes are rapidly turned over (Zaidel-Bar et al., 2003), so the presence of 
small punctate adhesions at dynamic membrane structures may account for the 
increased rate of STRAP null fibroblast motility.  However, the presence of large, 
centrally-located foci in STRAP null MEFs may inhibit tail retraction due to increased 
stabilization of focal adhesions.  It has recently been reported that myosin IIB stabilizes 
actin bundles in the cell rear and promotes the formation of large, mature cell adhesions 
(Vincente-Manzanares et al., 2011).  Although tail retraction was not specifically 
examined, overexpression of myosin IIB was shown to markedly hinder focal adhesion 
turnover in favor of focal adhesion maturation (Vincente-Manzanares et al., 2011).   
Interestingly, ectopic expression of STRAP in STRAP null MEFs increased peripheral 
pFAK staining and decreased tail formation.  STRAP was not identified as a component 
in purified focal adhesions (Kuo et al., 2011), so it is unlikely that STRAP regulates 
adhesion dynamics by directly affecting FAK localization to focal complexes.   
 In order to determine whether STRAP regulates focal adhesion disassembly, wild 
type and STRAP null MEFs were treated with nocodazole to inhibit β-tubulin 
polymerization and focal adhesions were monitored by immunostaining for pFAK Y397 
at various times after nocodazole washout.  After nocodazole washout, wild type MEFs 
began spreading but maintained peripheral focal adhesions.  Conversely, the STRAP 
null MEFs appeared to have a prominent ring of intense pFAK staining with weakly 
stained protrusions extending beyond the internal ring. This may suggest that the wild 
type MEFs assemble and disassemble focal adhesions at a comparable rate whereas 
the STRAP knockout MEFs fail to disassemble the initial cortical adhesions but continue 
to form immature focal contacts at distal protrusions.   
 In the broad context of cancer, cell migration and invasion are necessary for 
localized and distal tumor metastasis.  Previous studies have shown that MMP secretion 
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by carcinoma cells increases invasive capabilities (Powell et al., 1993; Juarez et al., 
1993) and may be correlated with tumor metastasis (Garbisa et al., 1992; Yoshimoto et 
al., 1993).  However, it has also been reported that expression of MMPs in the stromal 
compartment promotes invasion and metastasis (Zhang et al., 2006; Gorden et al., 
2007).  Gaggioli et al. have previously demonstrated that stromal fibroblasts generate 
invasive tracks that are subsequently utilized for the collective migration of epithelial 
tumor cells (Gaggioli et al., 2007).  As STRAP has been shown to promote MMP28 
expression (Swingler et al., 2010), it is possible that STRAP overexpression in stromal 
fibroblasts could support tumor metastasis through increased ECM remodeling.  In the 
event that STRAP null fibroblasts retain the ability to secrete MMPs, the apparent 
persistence defects may result in the generation of circuitous tracks surrounding a 
primary tumor .  As such, loss of stromal STRAP expression could favor local metastasis 
whereas STRAP-expressing fibroblasts could promote colonization of distant organ 
systems.   
 
   
 88 
 
Chaper IV 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 Much of the available data on STRAP suggests that it confers oncogenic 
properties to cells by regulating diverse signaling pathways (Reiner and Datta, 2011).  
These experimental findings are supported by the observation that STRAP is often up-
regulated in breast, colon, and lung tumors (Matsuda et al., 2000, Halder et al., 2006, 
Kim et al., 2007).  Previous studies have suggested that (a) STRAP promotes tumor 
growth by regulating mitogenic ERK signaling (Halder et al., 2006) and (b) STRAP 
regulates a morphological switches between mesenchymal and epithelioid phenotypes 
(Kashikar et al., 2010).  However, it had not been determined whether STRAP also 
regulates signaling through other MAPK pathways or whether STRAP-induced 
transdifferentiation was associated with changes in cell motility.  Herein, I have shown 
that STRAP has a functional role in the regulation of c-Jun stability as well as persistent 
migration.  In this section, the significance of these findings will be discussed in the 
context of cancer and future directions will be enumerated for each respective project.   
 
Significance of STRAP-mediated c-Jun stabilization and future directions 
 Because deregulated c-Jun expression promotes AP-1-induced tumor 
development (Jin et al., 2011; Sancho et al., 2009), normal cells limit c-Jun activity by 
regulating c-Jun expression.  I have shown that STRAP expression in fibroblasts is 
associated with increased c-Jun stability and increased proliferation.  Because AP-1 
activity promotes cell autonomous growth through transactivation of genes required for 
the G1/S transition, it is possible that STRAP-mediation stabilization of c-Jun could 
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promote cell autonomous growth of mesenchymal-derived tumors in vivo.  If STRAP also 
stabilizes c-Jun in epithelial cells, overexpression of STRAP could also promote 
carcinoma growth.  Further investigation into the effects of STRAP on c-Jun turnover in 
epithelial cell lines will be required to confirm this hypothesis, but the observation that 
STRAP regulates ERK and TGF-β signaling in fibroblasts and epithelial cell lines raises 
the possibility that STRAP can regulate c-Jun expression in both cell types (Datta and 
Moses, 2000; Halder et al., 2006). 
 In addition to cell autonomous growth, STRAP-mediated stabilization of c-Jun in 
fibroblasts could also promote paracrine tumor growth.  Within normal tissues, 
fibroblasts maintain tissue integrity through ECM maintenance and regulate epithelial 
cell homeostasis through growth factor secretion.  However, cancer associated 
fibroblasts (CAFs) have been reported to support tumorigenesis by modulating growth 
(Olumi et al., 1999; Cheng et al., 2005) and vascularization (Crawford et al., 2009;Zhang 
et al., 2011).  Furthermore, studies have shown that CAFs isolated from human tumor 
tissues exhibit increased loss of heterozygosity at genetic hotspots (Weber et al., 2006; 
Weber et al., 2007), suggesting that deregulated gene expression in stroma can 
influence epithelial tumor progression.  In the context of the tumor microenvironment, 
STRAP-expressing stromal fibroblasts could promote carcinoma growth through AP-1-
dependent secretion of growth factors.  It has previously been shown that increased AP-
1 signaling in fibroblasts promotes secretion of KGF, GM-CSF, and IGF (Maas-
Szabowski et al., 2001; Li et al., 2007).  Importantly, these soluble factors were reported 
to promote keratinocyte growth and differentiation in organotypic co-cultures (Maas-
Szabowski et al., 2001) as well as stimulate BPH-1 growth in vitro (Li et al., 2007).  
Although STRAP LOH has not been reported in CAFs, a 35 fold increase in KGF 
expression was detected in wild type MEFs compared to STRAP null MEFs (data not 
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shown), suggesting that stabilization of c-Jun in fibroblasts promotes AP-1 
transactivation of growth factors.   
 Further work will be required to fully understand the mechanisms by which 
STRAP regulates c-Jun stability and to address the biological significance of these 
findings.  Given that STRAP regulates cell signaling events through direct association 
with numerous cellular proteins, identification of STRAP binding partners involved in 
protein degradation may point to potential mechanisms for STRAP mediated c-Jun 
stabilization.  To further examine the biological implications of this research, it will be 
necessary to confirm that STRAP promotes proliferation through increased AP-1 activity 
by rescuing the STRAP knockout MEF growth defect with exogenous c-Jun.  It will also 
be important to determine whether STRAP stabilizes c-Jun in epithelial cells and 
whether increased c-Jun stabilization affects cell autonomous growth.  It may also be 
worthwhile to investigate the potential effects of stromal STRAP expression on paracrine 
signaling.  As a first step, the expression of GM-CSF, KGF, and other growth factors 
should be validated by RT-PCR and ELISA to confirm that STRAP expression promotes 
the expression and secretion of AP-1 induced soluble factors.  Furthermore, the growth 
of normal epithelial and BPH cells should be evaluated in co-culture systems with wild 
type and STRAP null MEFs.  If preliminary data suggest that STRAP expression affects 
cell autonomous or paracrine growth of epithelial cells in vitro, tumor growth could be 
evaluated in vivo using immune-compromised mice (Table 4).   
 
Biological implications for STRAP-induced persistent migration  
and future directions 
 
 Local and systemic metastasis of tumor cells is dependent on a number of 
factors, including the ability of tumor cells to migrate from the primary tumor to  
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Table 4.  Mouse models for assessing the effects of STRAP on AP-1 induced cell 
autonomous and paracrine growth.   
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a new colonization site.   The seed and soil hypothesis posits that tissue 
microenvironment exerts selective pressures on cells which serve to restrict tumor cell 
colonization to organ systems that provide the requisite growth conditions.  Alternatively, 
previous studies have shown that tumor cells preferentially migrate to specific organs in 
response to chemoattractant signals (Orr et al., 1985; Xu et al., 2009; Gassmann et al., 
2009).  Herein, I have shown that STRAP regulates persistent migration, tail retraction, 
and focal adhesion distribution in fibroblasts.  In the context of chemoattractant-driven 
metastasis, it is possible that STRAP expression can promote tumor metastasis through 
regulation of persistent migration towards tissues that secrete chemoattractants.      
 It has previously been shown that fibroblasts generate leading tracks that are 
utilized by carcinoma cells for metastasis from primary tumors (Gaggioli et al., 2007).  
Based on this finding, STRAP expression in fibroblasts may support epithelial tumor cell 
metastasis by creating a path towards a metastatic site.  It remains to be determined 
whether STRAP expression in trailing epithelial tumor cells is also required for efficient 
metastasis.  Preliminary data using STRAP knockdown HT29 colon carcinoma cells 
suggests that STRAP promotes migration of epithelial cells towards chemoattractants.  
As such, it seems likely that STRAP expression in stromal fibroblasts and epithelial 
tumors would promote persistent migration and metastasis.   
 Future investigation into the role of STRAP in cell motility should be aimed at 
examining potential mechanisms regulating persistence and adhesion.  To this end, it  
may be useful to perform affinity purification and mass spectrometry to identify STRAP- 
binding partners that regulate migration and focal adhesion dynamics.  In addition to 
influencing cell signaling pathways through protein-protein interactions, STRAP may be 
up-regulating the expression of adhesion and motility proteins.  Large scale proteomic 
analysis using multiplexed antibody arrays could be used to investigate differences in 
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the protein expression profiles between wild type and STRAP null fibroblasts.  As 
extracellular matrix proteins have been reported to affect cell phenotype and biological 
response (Dekkers et al., 2006), it will be important to consider these variables when 
conducting future experiments.  Because the Rho family of proteins are central 
regulators of motility, the spatial and temporal activation of RhoA, Rac1, and Cdc42 
should be examined in migrating cells by FRET analysis.  To further explore the role of 
STRAP in adhesion, it may be useful to characterize the effects of STRAP on focal 
adhesion assembly and disassembly in real time by using fluorescently-tagged focal 
adhesion proteins (Webb et al., 2004).  Because the cell tails are less evident in 
stationery cells, it would be most informative to investigate the kinetics of adhesion 
formation and turnover at both the leading and trailing edges in migrating cells.   
 In addition to these mechanistic studies, it will be important to address the clinical 
relevance of these data.  Loss of STRAP adversely affects embryonic development 
(Chen et al., 2004), possibly due to a failure in directed migration.  Post-development 
attenuation of STRAP expression could potentially affect wound healing processes and 
immunological function.  Conversely, overexpression of STRAP in tumors could promote 
tumor metastasis.  Although STRAP overexpression has been reported in breast, lung, 
and colon tumor tissue (Matsuda et al., 2000; Halder et al., 2006), a correlation between 
STRAP expression level and incidence of metastasis has not been investigated.  Until 
sufficient clinical data becomes available, animal models may serve as a useful tool to 
address this question.  It has previously been reported that the colon adenocarcinoma 
cell line, HT29, spontaneously colonize the lungs of severe combined immunodeficiency 
(SCID) mice after subcutaneous implantation (Mitchell et al., 1997; Jojovic and 
Schumacher, 2000).  Given that STRAP knockdown in HT29 cells decreases migration 
in Boyden chamber assays, it is possible that STRAP knockdown may decrease the 
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number of lung metastases relative to the appropriate controls.  Swingler et al. have 
recently reported that STRAP functions as a co-factor for MMP28 transactivation in 
HeLa cells (Swingler et al., 2010).  However, MMP28 is not expressed in HT29 cells 
(Lohi et al., 2001) and is down-regulated in inflammed colon and colon tumor epithelia 
(Bister et al., 2004).  Provided that STRAP does not directly regulate expression of other 
MMPs, this model would provide a means of dissecting out the role of STRAP on tumor 
cell migration and metastasis independent of its effects on matrix degradation.      
 
 
Concluding remarks 
 Collectively, the work presented herein further supports a role for STRAP in 
cancer development.  Thus far, the literature on STRAP focuses on its cell autonomous 
functions.  Although these studies directly examine the cell autonomous effects of 
STRAP on c-Jun expression and motility in fibroblasts, there is increasing evidence that 
stromal cells play an important role in cancer progression.  It has been reported that AP-
1 signaling in fibroblasts promotes growth factor secretion (Maas-Szabowski et al., 2001; 
Li et al., 2007)  and that fibroblast-mediated matrix remodeling permits tumor cell 
migration (Gaggioli et al., 2007).  In the context of these findings, it seems plausible that 
that stromal STRAP expression can contribute to tumor malignancy by stimulating 
paracrine growth and tumor metastasis.  However, much more work will be necessary to 
understand the cell autonomous and microenvironmental contributions of STRAP 
towards tumor development.   
 In the framework of the hallmarks of cancer (Hanahan and Weinberg; 2011), 
previous studies suggest that STRAP may influence multiple aspects of cancer 
progression (Figure 27).  Herein, I have shown that STRAP has a functional role in the 
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regulation of c-Jun stability and cell migration.  The effects of STRAP on these biological 
processes have the potential to enforce sustained proliferation and promote 
dissemination of tumor cells from primary tumors, respectively.   
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Figure 27.  Biological effects of STRAP on the hallmarks of cancer.  Updated 
hallmarks of cancer as described by Hanahan and Weinberg.  Icons corresponding to the 
classical hallmarks of cancer are depicted below with a description of the STRAP's 
contribution to these malignant properties.   Asterisks (*) indicate observations from 
dissertation research.   
Reprinted from Cell (2011) 144, 646-74 with permission from Elsevier 
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